<SEC-DOCUMENT>0000930413-21-000668.txt : 20210326
<SEC-HEADER>0000930413-21-000668.hdr.sgml : 20210326
<ACCEPTANCE-DATETIME>20210326172959
ACCESSION NUMBER:		0000930413-21-000668
CONFORMED SUBMISSION TYPE:	S-3ASR
PUBLIC DOCUMENT COUNT:		8
FILED AS OF DATE:		20210326
DATE AS OF CHANGE:		20210326
EFFECTIVENESS DATE:		20210326

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HEXCEL CORP /DE/
		CENTRAL INDEX KEY:			0000717605
		STANDARD INDUSTRIAL CLASSIFICATION:	PLASTICS, MATERIALS, SYNTH RESINS & NONVULCAN ELASTOMERS [2821]
		IRS NUMBER:				941109521
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-3ASR
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-254798
		FILM NUMBER:		21778699

	BUSINESS ADDRESS:	
		STREET 1:		TWO STAMFORD PLAZA
		STREET 2:		281 TRESSER BLVD., 16TH FLOOR
		CITY:			STAMFORD
		STATE:			CT
		ZIP:			06901
		BUSINESS PHONE:		203-969-0666

	MAIL ADDRESS:	
		STREET 1:		TWO STAMFORD PLAZA
		STREET 2:		281 TRESSER BLVD., 16TH FLOOR
		CITY:			STAMFORD
		STATE:			CT
		ZIP:			06901
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-3ASR
<SEQUENCE>1
<FILENAME>c101351_s3asr.htm
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As filed with the Securities and Exchange
Commission on March 26, 2021.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Registration No. 333-</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>



<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin: 0"><DIV STYLE="font-size: 1px; border-top: Black 1px solid; border-bottom: Black 1px solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->




<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1px solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 12pt"><B>FORM S-3</B></FONT><BR>
<FONT STYLE="font-size: 12pt"><B>REGISTRATION STATEMENT</B></FONT><BR>
<FONT STYLE="font-size: 11pt"><B><I>UNDER THE</I></B></FONT><BR>
<FONT STYLE="font-size: 11pt"><B><I>SECURITIES ACT OF 1933</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1px solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->




<P STYLE="font: 16pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>HEXCEL CORPORATION</B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Exact name of Registrant as specified
in its charter)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1px solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 3pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>


<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <TD STYLE="width: 45%; padding-right: 5.75pt; padding-left: 5.75pt; font: 9pt Times New Roman, Times, Serif; text-align: center"><font style="font-size: 9pt"><b>Delaware</b></font><br>
<font style="font-size: 9pt"><b>(State or other jurisdiction</b></font><br>
<font style="font-size: 9pt"><b>of incorporation or organization)</b></font></td>
    <TD STYLE="width: 10%">&nbsp;</TD>
    <TD STYLE="width: 45%; padding-right: 5.75pt; padding-left: 5.75pt; font: 9pt Times New Roman, Times, Serif; text-align: center"><font style="font-size: 9pt"><b>94-1109521</b></font><br>
<font style="font-size: 9pt"><b>(I.R.S. Employer</b></font><br>
<font style="font-size: 9pt"><b>Identification No.)</b></font></td></tr>
</table>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Two Stamford Plaza<BR>
281 Tresser Boulevard<BR>
Stamford, Connecticut 06901-3238<BR>
(203) 969-0666<BR>
(Address, including zip code, and telephone number, including area code, of Registrant&rsquo;s principal executive offices)</B></P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1px solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->



<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Gail E. Lehman, Esq.<BR>
Executive Vice President, General Counsel and Secretary<BR>
Hexcel Corporation<BR>
281 Tresser Boulevard<BR>
Stamford, Connecticut 06901<BR>
(203) 969-0666<BR>
(Name, address, including zip code, and telephone number, including area code, of agent for service)</B></P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1px solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->



<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I>With a copy to:</I><BR>
Andrew J. Nussbaum, Esq.<BR>
Gordon S. Moodie, Esq.<BR>
Kathryn Gettles-Atwa, Esq.<BR>
Wachtell, Lipton, Rosen&nbsp;&amp; Katz<BR>
51 West 52nd Street<BR>
New York, New York 10019<BR>
(212) 403-1000</B></P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 16.5pt"><B>Approximate date of commencement of proposed sale
to the public: </B>From time to time after this registration statement becomes effective.</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 16.5pt">If the only securities being registered on this Form
are being offered pursuant to dividend or interest reinvestment plans, please check the following box. <FONT STYLE="font-family: Wingdings ">o</FONT></P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 16.5pt">If any of the securities being registered on this
Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act, other than securities offered
only in connection with dividend or interest reinvestment plans, check the following box.  <FONT STYLE="font-family: Wingdings">x</FONT></P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 16.5pt">If this Form is filed to register additional securities
for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration
statement number of the earlier effective registration statement for the same offering:  <FONT STYLE="font-family: Wingdings">o</FONT></P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 16.5pt">If this Form is a post-effective amendment filed pursuant
to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the
earlier effective registration statement for the same offering:  <FONT STYLE="font-family: Wingdings">o</FONT></P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 16.5pt">If this Form is a registration statement pursuant
to General Instruction I.D. or a post-effective amendment thereto that shall become effective upon filing with the Commission pursuant
to Rule 462(e) under the Securities Act, check the following box.  <FONT STYLE="font-family: Wingdings">x</FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><page></page></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin: 0"><DIV STYLE="font-size: 1px; border-top: Black 1px solid; border-bottom: Black 1px solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->


<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 16.5pt">If this Form is a post-effective amendment to a registration
statement filed pursuant to General Instruction I.D. filed to register additional securities or additional classes of securities
pursuant to Rule 413(b) under the Securities Act, check the following box.  <FONT STYLE="font-family: Wingdings">o</FONT></P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 16.5pt"></P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 16.55pt">Indicate by check mark whether the registrant
is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth
company. See the definitions of &ldquo;large accelerated filer,&rdquo; &ldquo;accelerated filer,&rdquo; &ldquo;smaller reporting
company&rdquo; and &ldquo;emerging growth company&rdquo; in Rule 12b-2 of the Exchange Act.</P>

<P STYLE="font: 3pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 16.55pt">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="width: 100%; background-color: white; border-collapse: collapse">
<tr style="vertical-align: bottom; background-color: Transparent">
    <td style="width: 21%; font: 9pt Times New Roman, Times, Serif"><font style="font-size: 9pt">Large accelerated filer</font></td>
    <td style="width: 1%">&nbsp;</td>
    <td style="width: 48%; font: 9pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Wingdings">x</FONT></td>
    <td style="width: 1%">&nbsp;</td>
    <td style="width: 26%; font: 9pt Times New Roman, Times, Serif"><font style="font-size: 9pt">Accelerated filer</font></td>
    <td style="width: 1%">&nbsp;</td>
    <td style="width: 2%; font: 9pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Wingdings">o</FONT></td></tr>
<tr style="vertical-align: bottom; background-color: Transparent">
    <td style="font: 9pt Times New Roman, Times, Serif"><font style="font-size: 9pt">Non-accelerated filer</font></td>
    <td>&nbsp;</td>
    <td style="font: 9pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Wingdings">o</FONT><font style="font-size: 9pt">&nbsp;&nbsp;(Do not check if a smaller reporting company)</font></td>
    <td>&nbsp;</td>
    <td style="font: 9pt Times New Roman, Times, Serif"><font style="font-size: 9pt">Smaller reporting company</font></td>
    <td>&nbsp;</td>
    <td style="font: 9pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Wingdings">o</FONT></td></tr>
<tr style="vertical-align: bottom; background-color: Transparent">
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td style="font: 9pt Times New Roman, Times, Serif"><font style="font-size: 9pt">Emerging growth company</font></td>
    <td>&nbsp;</td>
    <td style="font: 9pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Wingdings">o</FONT></td></tr>
</table>
<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.75pt">If an emerging growth company, indicate by check mark
if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 7(a)(2)(B) of Securities Act. <FONT STYLE="font-family: Wingdings">o</FONT></P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.75pt">&nbsp;</P>


<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1px solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->


<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CALCULATION OF REGISTRATION FEE</B></P>


<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin: 0"><DIV STYLE="font-size: 1px; border-top: Black 1px solid; border-bottom: Black 1px solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->


<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 9pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <TD STYLE="width: 36%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center; border-bottom: Black 1px solid"><font style="font-size: 9pt"><b>Title of Each Class of Securities</b></font><br>
<font style="font-size: 9pt"><b>to be Registered</b></font></td>
    <TD STYLE="width: 3%; border-bottom: Black 1px solid">&nbsp;</TD>
    <TD STYLE="width: 40%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center; border-bottom: Black 1px solid"><font style="font-size: 9pt"><b>Amount to be Registered/</b></font><br>
<font style="font-size: 9pt"><b>Proposed Maximum Offering Price Per Unit/</b></font><br>
<font style="font-size: 9pt"><b>Proposed Maximum Aggregate Offering Price<sup>(1)</sup></b></font></td>
    <TD STYLE="width: 3%; border-bottom: Black 1px solid">&nbsp;</TD>
    <TD STYLE="width: 18%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center; border-bottom: Black 1px solid"><font style="font-size: 9pt"><b>Amount of</b></font><br>
<font style="font-size: 9pt"><b>Registration Fee</b></font></td></tr>
<tr style="vertical-align: bottom">
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; border-bottom: Black 1px solid"><font style="font-size: 9pt">Debt Securities</font></td>
    <TD STYLE="border-bottom: Black 1px solid">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; border-bottom: Black 1px solid">&nbsp;</td>
    <TD STYLE="border-bottom: Black 1px solid">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; border-bottom: Black 1px solid">&nbsp;</td></tr>
<tr style="vertical-align: bottom">
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; border-bottom: Black 1px solid"><font style="font-size: 9pt">Common Stock, par value $0.01 per share</font></td>
    <TD STYLE="border-bottom: Black 1px solid">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; border-bottom: Black 1px solid">&nbsp;</td>
    <TD STYLE="border-bottom: Black 1px solid">&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt; border-bottom: Black 1px solid">&nbsp;</td></tr>
<tr style="vertical-align: bottom">
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt"><font style="font-size: 9pt">Preferred Stock, no par value</font></td>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt">&nbsp;</td>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 5.75pt; padding-left: 5.75pt">&nbsp;</td></tr>
</table>
<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin: 0"><DIV STYLE="font-size: 1px; border-top: Black 1px solid; border-bottom: Black 1px solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->
<table cellspacing="0" cellpadding="0" style="font: 9pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <TD STYLE="width: 4%"><font style="font-size: 9pt">(1)</font></td>
    <TD STYLE="width: 96%; padding-bottom: 5pt"><font style="font-size: 9pt; background-color: white">An indeterminate aggregate initial offering price, principal amount or number of the securities of each identified class is being registered as may from time to time be issued at indeterminate prices or upon conversion, exchange or exercise of securities registered hereunder to the extent any such securities are, by their terms, convertible into, or exchangeable or exercisable for, such securities. Securities registered hereunder may be sold either separately or as units comprised of more than one type of security registered hereunder. Separate consideration may or may not be received for securities that are issuable on exercise, conversion or exchange of other securities or that are issued in units. In accordance with Rule 456(b) and Rule 457(r) under the Securities Act of 1933, as amended, the registrant is deferring payment of all of the registration fees.</font></td></tr>
</table>
<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin: 0"><DIV STYLE="font-size: 1px; border-top: Black 1px solid; border-bottom: Black 1px solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->
<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><page></page></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>Prospectus</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><IMG SRC="x1_c101351x4x1.jpg" ALT=""></P>

<P STYLE="font: 9pt Sans-Serif; margin: 0pt 0; text-align: center; background-color: white; color: Red">&nbsp;</P>

<P STYLE="font: 20pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>HEXCEL CORPORATION</B></P>

<P STYLE="font: 20pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>Debt Securities</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>Common Stock</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>Preferred Stock</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1px solid; width: 40%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">We may use this prospectus from time to time
to offer debt securities, shares of our common stock or shares of our preferred stock. We refer to our debt securities, common
stock and preferred stock collectively as the &ldquo;securities.&rdquo; Any or all of the securities may be offered and sold separately
or together. The securities may be convertible into or exchangeable or exercisable for other securities. We may offer and sell
these securities through underwriters, dealers or agents or directly to purchasers, on a continuous or delayed basis. We will provide
specific terms of these securities, and the manner in which these securities will be offered, in supplements to this prospectus.
The prospectus supplements may also add, update or change information contained in this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">Our common stock is listed on the New York
Stock Exchange under the symbol &ldquo;HXL.&rdquo; Each prospectus supplement will indicate if the securities offered thereby will
be listed on any securities exchange.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1px solid; width: 40%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">Investing in the securities involves
risks. You should carefully read this prospectus and the applicable prospectus supplement, including the section entitled &ldquo;Risk
Factors&rdquo; beginning on page 2 of this prospectus, the section entitled &ldquo;Risk Factors&rdquo; in the applicable prospectus
supplement and risk factors in our periodic reports and other information filed with the Securities and Exchange Commission before
investing in the securities.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1px solid; width: 40%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt"><FONT STYLE="font-weight: normal">Neither
the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined
if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1px solid; width: 40%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">This prospectus is dated March 26,
2021</P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><page></page></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->


<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">TABLE OF CONTENTS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-family: Times New Roman, Times, Serif">
<tr style="vertical-align: top">
    <td style="width: 95%; font-size: 10pt"><a href="#x1_c101351a001">ABOUT THIS PROSPECTUS</a></td>
    <td style="width: 5%; font-size: 10pt; text-align: right">ii</td></tr>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD></TR>
<tr style="vertical-align: top">
    <td style="font-size: 10pt"><a href="#x1_c101351a002">FORWARD-LOOKING STATEMENTS</a></td>
    <td style="font-size: 10pt; text-align: right">ii</td></tr>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD></TR>
<tr style="vertical-align: top">
    <td style="font-size: 10pt"><a href="#x1_c101351a003">SUMMARY</a></td>
    <td style="font-size: 10pt; text-align: right">1</td></tr>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD></TR>
<tr style="vertical-align: top">
    <td style="font-size: 10pt"><a href="#x1_c101351a004">RISK FACTORS</a></td>
    <td style="font-size: 10pt; text-align: right">2</td></tr>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD></TR>
<tr style="vertical-align: top">
    <td style="font-size: 10pt"><a href="#x1_c101351a005">USE OF PROCEEDS</a></td>
    <td style="font-size: 10pt; text-align: right">2</td></tr>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD></TR>
<tr style="vertical-align: top">
    <td style="font-size: 10pt"><a href="#x1_c101351a006">SECURITIES WE MAY OFFER</a></td>
    <td style="font-size: 10pt; text-align: right">2</td></tr>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD></TR>
<tr style="vertical-align: top">
    <td style="font-size: 10pt"><a href="#x1_c101351a007">DESCRIPTION OF DEBT SECURITIES</a></td>
    <td style="font-size: 10pt; text-align: right">2</td></tr>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD></TR>
<tr style="vertical-align: top">
    <td style="font-size: 10pt"><a href="#x1_c101351a008">DESCRIPTION OF CAPITAL STOCK</a></td>
    <td style="font-size: 10pt; text-align: right">5</td></tr>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD></TR>
<tr style="vertical-align: top">
    <td style="font-size: 10pt"><a href="#x1_c101351a009">PLAN OF DISTRIBUTION</a></td>
    <td style="font-size: 10pt; text-align: right">10</td></tr>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD></TR>
<tr style="vertical-align: top">
    <td style="font-size: 10pt"><a href="#x1_c101351a010">LEGAL MATTERS</a></td>
    <td style="font-size: 10pt; text-align: right">12</td></tr>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD></TR>
<tr style="vertical-align: top">
    <td style="font-size: 10pt"><a href="#x1_c101351a011">EXPERTS</a></td>
    <td style="font-size: 10pt; text-align: right">12</td></tr>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD></TR>
<tr style="vertical-align: top">
    <td style="font-size: 10pt"><a href="#x1_c101351a012">WHERE YOU CAN FIND MORE INFORMATION</a></td>
    <td style="font-size: 10pt; text-align: right">12</td></tr>
</table>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><A NAME="x1_c101351a001"></A>ABOUT THIS
PROSPECTUS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">This prospectus is part of an automatic shelf
registration statement that we filed with the Securities and Exchange Commission (&ldquo;SEC&rdquo;) as a &ldquo;well-known seasoned
issuer,&rdquo; as defined in Rule 405 under the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;). Under this
shelf registration, we may, from time to time, sell an indeterminate amount of any combination of common stock, debt securities
or preferred stock described in this prospectus in one or more offerings. We may also issue other securities upon conversion, exchange
or exercise of any of the securities mentioned above. The registration statement that contains this prospectus (including the exhibits
to the registration statement) contains additional information about us and the securities we may offer under this prospectus and
any prospectus supplement. You can read that registration statement at the SEC website at http://www.sec.gov mentioned under the
heading &ldquo;Where You Can Find More Information.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">This prospectus describes the general terms
of the securities we may offer. Each time we sell securities, we will provide a prospectus supplement that will describe the specific
amounts, prices and other terms of that offering. The prospectus supplement prepared by us or on our behalf may also add, update
or change information contained in this prospectus. To understand the terms of the securities that may be offered pursuant to this
prospectus, you should carefully read this document with the applicable prospectus supplement or any free writing prospectus prepared
by us or on our behalf. Together, these documents will give the specific terms of the offered securities. You should also read
the documents we have incorporated by reference in this prospectus and any applicable prospectus supplement and the additional
information described below under &ldquo;Where You Can Find More Information.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">We may also prepare free writing prospectuses
that describe particular securities. Any free writing prospectus should also be read in connection with this prospectus and with
any prospectus supplement referred to in that free writing prospectus. For purposes of this prospectus, any reference to a prospectus
supplement may also refer to a free writing prospectus unless the context requires otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">You should rely only on the information
incorporated by reference or provided in this prospectus or any prospectus supplement prepared by us or on our behalf. We have
not authorized anyone else to provide you with different information. If anyone provides you with different or inconsistent information,
you should not rely on it. We are not making an offer to sell these securities in any jurisdiction where the offer or sale is not
permitted. You should not assume that the information in this prospectus, any prospectus supplement or any free writing prospectus
is accurate as of any date other than the date on the front of those documents.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">In this prospectus, unless otherwise indicated
herein or the context otherwise indicates, the terms &ldquo;Hexcel,&rdquo; &ldquo;we,&rdquo; &ldquo;us,&rdquo; &ldquo;our&rdquo;
and the &ldquo;Company&rdquo; refer to Hexcel Corporation, together with its consolidated subsidiaries. Currency amounts in this
prospectus are stated in United States, or U.S., dollars.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><A NAME="x1_c101351a002"></A>FORWARD-LOOKING
STATEMENTS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">Certain statements contained in this prospectus
and the information incorporated by reference constitute &ldquo;forward-looking statements&rdquo; within the meaning of the Private
Securities Litigation Reform Act of 1995. These statements relate to analyses and other information that are based on forecasts
of future results and estimates of amounts not yet determinable. These statements also relate to future prospects, developments
and business strategies. These forward-looking statements are identified by their use of terms and phrases such as &ldquo;anticipate,&rdquo;
&ldquo;believe,&rdquo; &ldquo;continue,&rdquo; &ldquo;could,&rdquo; &ldquo;estimate,&rdquo; &ldquo;expect,&rdquo; &ldquo;intend,&rdquo;
&ldquo;may,&rdquo; &ldquo;plan,&rdquo; &ldquo;potential,&rdquo; &ldquo;predict,&rdquo; &ldquo;project,&rdquo; &ldquo;should,&rdquo;
&ldquo;target,&rdquo; &ldquo;would,&rdquo; &ldquo;will&rdquo; and similar terms and phrases, including references to assumptions.
Such statements are based on current expectations, are inherently uncertain and are subject to changing assumptions. Such forward-looking
statements include, but are not limited to: (a) the estimates and expectations based on aircraft production rates provided by Airbus,
Boeing and others; (b) the revenues we may generate from an aircraft model or program; (c) the impact of the possible push-out
in deliveries of the Airbus and Boeing backlog and the impact of delays in the startup or ramp-up of new aircraft programs or the
final Hexcel composite material content once the design and material selection have been completed; (d) expectations with regard
to the build rate of the Boeing 737 MAX following its return to service and the related impact on our revenues (e) expectations
with regard to the timing of inventory de-stocking related to a decrease in customer demand caused by the COVID-19 pandemic; (f)
expectations of composite content on new commercial aircraft programs and our share of those requirements; (g)</P>

<!-- Field: Page; Sequence: 5; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; padding-bottom: 12pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><page></page></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0pt">expectations regarding revenues from space
and defense applications, including whether certain programs might be curtailed or discontinued; (h) expectations regarding sales
for wind energy, recreation, automotive and other industrial applications; (i) expectations regarding working capital trends and
expenditures and inventory levels; (j) expectations as to the level of capital expenditures and when we will complete the construction
of capacity expansions and qualification of new products; (k) expectations regarding our ability to maintain and improve margins
in view of the prevailing economic environment; (l) expectations regarding the outcome of legal matters or the impact of changes
in laws or regulations or government policies; (m) our projections regarding our tax rate; (n) expectations with regard to the
continued impact of the COVID-19 pandemic on worldwide air travel and aircraft programs, as well as on our customers and suppliers
and, in turn, on our operations and financial results; and (o) the anticipated impact of the above factors and various market risks
on our expectations of financial results for 2021 and beyond. Such forward-looking statements involve known and unknown risks,
uncertainties and other factors that may cause actual results to be materially different. Such factors include, but are not limited
to, the following: the impact of the COVID-19 pandemic (including continued disruption in global financial markets, ongoing restrictions
on movement and travel, employee absenteeism and reduced consumer demand for air travel) on the operations, business and financial
condition of Hexcel and its customers and suppliers, reductions in sales to any significant customers, particularly Airbus or Boeing,
including reduction in revenue related to the timing of ramp-up of production of the Boeing 737 MAX, as well as due to the impact
of the COVID-19 pandemic; our ability to effectively adjust production and inventory levels to align with reduced demand; inability
to effectively motivate, retain and hire necessary workforce; our ability to successfully implement or realize our business strategies,
plans and objectives of management, including any restructuring or alignment activities in which we may engage; timing of inventory
de-stocking caused by the COVID-19 pandemic; changes in sales mix; changes in current pricing and cost levels; changes in aerospace
delivery rates; changes in government defense procurement budgets; changes in military aerospace program technology; timely new
product development or introduction; industry capacity; increased competition; availability and cost of raw materials and supply
chain disruptions; our ability to install, staff and qualify necessary capacity or complete planned manufacturing improvements
to meet customer demand; cybersecurity breaches or intrusions; currency exchange rate fluctuations; changes in political, social
and economic conditions; including, but not limited to, the effect of change in global trade policies and the impact of the exit
of the U.K. from the European Union; work stoppages or other labor disruptions; our ability to successfully complete any strategic
acquisitions, investments or dispositions, compliance with environmental, health, safety and other related laws and regulations;
and the unexpected outcome of legal matters or impact of changes in laws or regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">Although we believe that these forward-looking
statements are based on reasonable assumptions, you should be aware that many factors could affect our actual results of operations
and could cause actual results to differ materially from those expressed in the forward-looking statements. As a result, the foregoing
factors should not be construed as exhaustive and should be read together with other cautionary statements included in our other
filings with the SEC. For additional information regarding certain factors that may cause our actual results to differ from those
expected or anticipated see the information under the caption &ldquo;Risk Factors&rdquo; which is located in Item 1A of Part I
of our Annual Report on Form 10-K for the year ended December 31, 2020. We do not undertake any obligation to update our forward-looking
statements or risk factors to reflect future events or circumstances, except as otherwise required by law.</P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; padding-bottom: 12pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iii<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><page></page></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<DIV STYLE="padding: 10pt; border: Black 1px solid">
<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><A NAME="x1_c101351a003"></A>SUMMARY</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">About Hexcel Corporation</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt"><FONT STYLE="background-color: white">Hexcel
is a leading advanced composites company. We develop, manufacture, and market lightweight, high-performance structural materials,
including carbon fibers, specialty reinforcements, prepregs and other fiber-reinforced matrix materials, honeycomb, adhesives,
radio frequency / electromagnetic interference (&ldquo;RF/EMI&rdquo;) and microwave absorbing materials, engineered honeycomb and
composite structures, for use in Commercial Aerospace, Space&nbsp;&amp; Defense, and Industrial markets. Our products are used
in a wide variety of end applications, such as commercial and military aircraft, space launch vehicles and satellites, wind turbine
blades, automotive, recreational products, and other industrial applications.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">Our principal executive offices are located
at Two Stamford Plaza, 281 Tresser Boulevard, Stamford, Connecticut 06901, and our telephone number at that location is (203) 969-0666.</P>
<P STYLE="font: 250pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>
</div>

<!-- Field: Page; Sequence: 7; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; padding-bottom: 12pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><page></page></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><A NAME="x1_c101351a004"></A>RISK FACTORS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">Before you decide to invest in our securities,
you should carefully consider the specific risks set forth under the caption &ldquo;Risk Factors&rdquo; contained in any applicable
prospectus supplement and any related free writing prospectus, and under similar headings in our Annual Report on Form 10-K for
the year ended December 31, 2020, as updated by annual, quarterly and other reports and documents we file with the SEC after the
date of this prospectus and that are incorporated by reference in this prospectus and in any prospectus supplement for your securities,
and in the other documents that are incorporated by reference in this prospectus and any prospectus supplement for your securities.
For more information, see &ldquo;Where You Can Find More Information.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">In addition to those risk factors, there
may be additional risks and uncertainties of which management is not aware or on which management is not focused or that management
deems immaterial. Our business, financial condition or results or operations could be materially adversely affected by any of these
risks. The trading price of our securities could decline due to any of these risks, and you may lose all or part of your investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><A NAME="x1_c101351a005"></A>USE OF PROCEEDS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">We do not currently know the number or types
of securities that ultimately will be sold pursuant to this prospectus or the prices at which such securities will be sold. Unless
the applicable prospectus supplement states otherwise, we intend to use the net proceeds from the sale of the offered securities
for general corporate purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><A NAME="x1_c101351a006"></A>SECURITIES
WE MAY OFFER</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">This prospectus contains summary descriptions
of the debt securities, common stock and preferred stock that we may offer and sell from time to time. These summary descriptions
are not meant to be complete descriptions of each security. The particular terms of any security will be described in the applicable
prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><A NAME="x1_c101351a007"></A>DESCRIPTION
OF DEBT SECURITIES</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">We may offer unsecured debt securities in
one or more series which may be senior or subordinated, and which may be convertible into another security.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">The following description briefly sets forth
certain general terms and provisions of the debt securities. The particular terms of the debt securities offered by any prospectus
supplement and the extent, if any, to which the following general terms and provisions may apply to those debt securities, will
be described in the applicable prospectus supplement. Unless otherwise specified in the applicable prospectus supplement, each
series of our debt securities will be issued under the indenture, dated as of August 3, 2015, between us and U.S. Bank National
Association, as trustee (the &ldquo;indenture&rdquo;). The indenture is attached as an exhibit to the registration statement of
which this prospectus forms a part. The terms of the debt securities will include those set forth in the indenture and those made
a part of the indenture by the Trust Indenture Act of 1939 (&ldquo;TIA&rdquo;). The indenture is subject to any amendments or supplements
that we may enter into from time to time, as permitted under the indenture. You should read the summary below, the applicable prospectus
supplement and the provisions of the indenture and applicable indenture supplement, if any, in their entirety before investing
in our debt securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">The aggregate principal amount of debt securities
that may be issued under the indenture is unlimited. The prospectus supplement relating to any series of debt securities that we
may offer will contain the specific terms of that series of debt securities. Authorizing resolutions, a certificate or a supplemental
indenture will set forth the specific terms of each series of debt securities. These terms may include, among others, the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>the title and aggregate principal amount of the debt securities and any limit on the aggregate principal amount;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>whether the debt securities will be senior, subordinated or junior subordinated;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>any applicable subordination provisions for any subordinated debt securities;</TD></TR></TABLE>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; padding-bottom: 12pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><page></page></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>the maturity date(s) or the method for determining same;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>the interest rate(s) or the method for determining same;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>the dates on which interest will accrue or the method for determining dates on which interest will accrue and dates on which
interest will be payable and whether interest shall be payable in cash, additional securities or some combination thereof;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>whether the debt securities are convertible or exchangeable into other securities and any related terms and conditions;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>redemption or early repayment provisions;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>authorized denominations;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>if other than the principal amount, the principal amount of debt securities payable upon acceleration;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>place(s) where payment of principal and interest may be made, where debt securities may be presented and where notices or demands
upon the company may be made;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>whether such debt securities will be issued in whole or in part in the form of one or more global securities and the date as
of which the securities are dated if other than the date of original issuance;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>amount of discount or premium, if any, with which such debt securities will be issued;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>any additions to or changes in the covenants that apply to such debt securities;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>any additions or changes in the defaults and events of default applicable to the particular or series of debt securities being
issued;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>the guarantors of each series, if any, and the extent of the guarantees (including provisions relating to seniority, subordination
and release of the guarantees), if any;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>the currency, currencies or currency units in which the purchase price for, the principal of and any premium and any interest
on, such debt securities will be payable;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>our obligation or right to redeem, purchase or repay debt securities under a sinking fund, amortization or analogous provision;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>any restriction or conditions on the transferability of the debt securities;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>provisions granting special rights to holders of the debt securities upon occurrence of specified events;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>additions or changes relating to compensation or reimbursement of the trustee of the series of debt securities;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>additions or changes to the provisions for the defeasance of the debt securities or to provisions related to satisfaction and
discharge of the indenture;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>provisions relating to the modification of the indenture both with and without the consent of holders of debt securities issued
under the indenture and the execution of supplemental indentures for such series; and</TD></TR></TABLE>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; padding-bottom: 12pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><page></page></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>any other terms of the debt securities (which terms shall not be inconsistent with the provisions of the TIA, but may modify,
amend, supplement or delete any of the terms of the indenture with respect to such series debt securities).</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">General</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">We may sell the debt securities, including
original issue discount securities, at par or at a substantial discount below their stated principal amount. Unless we inform you
otherwise in a prospectus supplement, we may issue additional debt securities of a particular series without the consent of the
holders of any other debt securities of such series or any other series outstanding at the time of issuance. Any such additional
debt securities, together with all other outstanding debt securities of that series, will constitute a single series of securities
under the indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">We will describe in the applicable prospectus
supplement any other special considerations for any debt securities we sell which are denominated in a currency or currency unit
other than U.S. dollars. In addition, debt securities may be issued where the amount of principal and/or interest payable is determined
by reference to one or more currency exchange rates, commodity prices, equity indices or other factors. Holders of such securities
may receive a principal amount or a payment of interest that is greater than or less than the amount of principal or interest otherwise
payable on such dates, depending upon the value of the applicable currencies, commodities, equity indices or other factors. Information
as to the methods for determining the amount of principal or interest, if any, payable on any date, and the currencies, commodities,
equity indices or other factors to which the amount payable on such date is linked, will be described in the applicable prospectus
supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">United States federal income tax consequences
and special considerations, if any, applicable to any such series will be described in the applicable prospectus supplement. Unless
we inform you otherwise in the applicable prospectus supplement, the debt securities will not be listed on any securities exchange.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">We expect most debt securities to be issued
in fully registered form without coupons and in denominations of U.S. $2,000 and any integral multiple of $1,000 in excess thereof.
Subject to the limitations provided in the indenture and in the applicable prospectus supplement, debt securities that are issued
in registered form may be transferred or exchanged at the designated corporate trust office of the trustee, without the payment
of any service charge, other than any tax or other governmental charge payable in connection therewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Global Securities</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">Unless we inform you otherwise in the applicable
prospectus supplement, the debt securities of a series may be issued in whole or in part in the form of one or more global securities
that will be deposited with, or on behalf of, a depositary identified in the applicable prospectus supplement. Global securities
will be issued in registered form and in either temporary or definitive form. Unless and until it is exchanged in whole or in part
for the individual debt securities, a global security may not be transferred except as a whole by the depositary for such global
security to a nominee of such depositary or by a nominee of such depositary to such depositary or another nominee of such depositary
or by such depositary or any such nominee to a successor of such depositary or a nominee of such successor. The specific terms
of the depositary arrangement with respect to any debt securities of a series and the rights of and limitations upon owners of
beneficial interests in a global security will be described in the applicable prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Governing Law</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">The indenture and the debt securities shall
be construed in accordance with and governed by the laws of the State of New York.</P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; padding-bottom: 12pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><page></page></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><A NAME="x1_c101351a008"></A>DESCRIPTION
OF CAPITAL STOCK</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Authorized Capital</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">The Company&rsquo;s authorized capital stock
consists of 200,000,000 shares of common stock, $0.01 par value per share, and 20,000,000 shares of preferred stock, no par value.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">Under Delaware law, the stockholders of a
corporation are generally not personally liable for a corporation&rsquo;s acts or debts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Common Stock</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">As of March 15, 2021, 83,725,385 shares
of common stock were issued and outstanding and held by approximately 463 record holders. Holders of the common stock are
entitled to one vote for each share of common stock held of record on each matter submitted to a vote of stockholders and to
vote on all matters on which a vote of stockholders is taken, except as otherwise provided by statute. There is no cumulative
voting with respect to the election of directors. The Company&rsquo;s amended and restated bylaws (&ldquo;Bylaws&rdquo;)
provide for a majority voting standard for the election of directors in uncontested elections, and under this standard,
directors are elected by a majority of the votes cast by holders of the common stock. If a nominee who currently is serving
as a director is not re-elected, Delaware law provides that the director will continue to serve on the Company&rsquo;s board
of directors (the &ldquo;Board of Directors&rdquo;). However, each incumbent director nominee standing for re-election must
submit an irrevocable resignation in advance of the stockholder vote regarding the election of directors. The resignation is
contingent upon both the director not receiving the required vote for re-election and the Board of Directors&rsquo;
acceptance of the resignation, which the Board of Directors, in its discretion, may reject if it deems such rejection to be
in the best interest of the Company. In the case of contested elections (a situation in which the number of nominees exceeds
the number of directors to be elected), directors are elected by a plurality of the votes cast by holders of the common
stock. Except as otherwise required by law, all other matters brought to a vote of the holders of the common stock are
determined by a majority of the shares of common stock present in person or represented by proxy and entitled to vote and,
except as may be provided with respect to any other outstanding class or series of the Company&rsquo;s stock, the holders of
shares of common stock possess the exclusive voting power.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Dividends</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">Subject to the preferential rights of the
holders of any then-outstanding shares of any series of preferred stock, the holders of the common stock are entitled to receive
dividends, if any, as may be declared from time to time by the Board of Directors in its discretion from funds legally available
therefor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Rights and Preferences</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">Holders of the common stock have no preemptive
rights or other rights to subscribe for additional shares and no conversion rights. The common stock is not subject to redemption
or to any sinking fund provisions, and all outstanding shares of common stock are fully paid and nonassessable. The rights, preferences
and privileges of the holders of the common stock are subject to, and may be adversely affected by, the rights of the holders of
shares of any series of preferred stock that the Company may designate and issue in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">Upon liquidation, dissolution or winding
up of the Company, holders of the common stock are entitled to their pro rata share of the assets of the Company legally available
for distribution to stockholders after the payment of all of the Company&rsquo;s known debts and liabilities, subject to the preferential
rights of the holders of shares of any series of preferred stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Exchange and Trading Symbol</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The common stock is listed for trading on
the New York Stock Exchange under the trading symbol &ldquo;HXL.&rdquo;</P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; padding-bottom: 12pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><page></page></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Preferred Stock</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Company may issue preferred stock from
time to time upon the approval of the Board of Directors in one or more series without further stockholder approval. The Board
of Directors may designate the number of shares to be issued in such series and the rights, preferences, privileges and restrictions
granted to, or imposed on, the holders of such shares. If issued, such shares of preferred stock could have dividends and liquidation
preferences and may otherwise affect the rights of holders of the common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">The rights of the holders of the common stock
will generally be subject to the rights of the holders of any existing outstanding shares of preferred stock with respect to dividends,
liquidation preferences and other matters. As of December 31, 2020, no shares of preferred stock were issued or outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">The specific terms of any preferred stock
to be sold under this prospectus will be described in a prospectus supplement. If so indicated in such prospectus supplement, the
terms of the preferred stock offered may differ from the general terms set forth below. Unless otherwise specified in the prospectus
supplement relating to the preferred stock offered thereby, each series of preferred stock offered will rank equal in right of
payment to all other series of our preferred stock, and holders thereof will have no preemptive rights. The preferred stock offered
will, when issued, be fully paid and nonassessable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">You should read the applicable prospectus
supplement for the terms of the preferred stock offered. The terms of the preferred stock set forth in such prospectus supplement
may include the following, as applicable to the preferred stock offered thereby:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>the title and stated value of the preferred stock;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>the liquidation preference and the offering price of the preferred stock;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>the dividend rates of the preferred stock and/or methods of calculation of such dividends;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>periods and/or payment dates for the preferred stock dividends;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>whether dividends on the preferred stock are cumulative;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>the liquidation rights of the preferred stock;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>the procedures for any auction and remarketing, if any, of the preferred stock;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>the sinking fund provisions, if applicable, for the preferred stock;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>the redemption provisions, if applicable, for the preferred stock;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>whether the preferred stock will be convertible into or exchangeable for other securities and, if so, the terms and conditions
of conversion or exchange, including the conversion price or exchange ratio and the conversion or exchange period or the method
of determining the same;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>whether the preferred stock will have voting rights and, if so, the terms of such voting rights;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>whether the preferred stock will be listed on any securities exchange;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>whether the preferred stock will be issued with any other securities and, if so, the amount and terms of such other securities;
and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>any other specific terms, preferences or rights of, or limitations or restrictions on, the preferred stock.</TD></TR></TABLE>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; padding-bottom: 12pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><page></page></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">The Board of Directors could issue a series
of preferred stock that could, depending on the terms of such series, delay, defer or prevent a change in control of the Company.
The Board of Directors would make any determination to issue such shares based on its judgment as to the best interests of our
Company and our stockholders. The Board of Directors, in so acting, could issue preferred stock having terms that could discourage
an attempt to acquire our Company, including tender offers or other transactions that some, or a majority, of our stockholders
might believe to be in their best interests, or in which our stockholders might receive a premium for their stock over the then
current market price of such stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Preferred Share Purchase Rights</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On April 6, 2020, the Board of Directors
declared a dividend of one preferred share purchase right (a &ldquo;Right&rdquo;) for each outstanding share of common stock, and
adopted a stockholder rights plan, as set forth in the Rights Agreement dated as of April 6, 2020 (the &ldquo;Rights
Agreement&rdquo;), by and between the Company and American Stock Transfer&nbsp;&amp; Trust Company, LLC, as rights agent. The dividend
was paid on April 16, 2020 to Company stockholders of record as of the close of business on April 16, 2020. <FONT STYLE="background-color: white">The
Rights will expire on April 6, 2021.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In general terms, the Rights Agreement works
by imposing a significant penalty upon any person or group which acquires 15% or more of the outstanding common stock without the
approval of the Board of Directors. The Rights Agreement would not interfere with any merger or other business combination approved
by the Board of Directors. A summary of the terms of the Rights Agreement is as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>The Rights</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Rights will initially trade with, and
will be inseparable from, the common stock. A Right will accompany any share of common stock issued after April 16, 2020 until
the Distribution Date (as defined below) or the earlier expiration, exchange or redemption of the Rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Exercise Price</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Each Right will allow its holder to purchase
from the Company one one-hundredth of a share of Series A Junior Participating preferred stock (a &ldquo;Series A Preferred Share&rdquo;)
for $150.00 (the &ldquo;Exercise Price&rdquo;), once the Rights become exercisable. This portion of a Series A Preferred Share
will give the stockholder approximately the same dividend, voting and liquidation rights as would one share of common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white"><I>Exercisability</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; background-color: white">The Rights will
not be exercisable until 10 days after the public announcement that a person or group has become an &ldquo;Acquiring Person&rdquo;
(as defined in the Rights Agreement) by obtaining beneficial ownership of 15% or more of the outstanding common stock. Prior to
exercise, the Right does not give its holder any dividend, voting, or liquidation rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; background-color: white">The date when the
Rights become exercisable is the &ldquo;Distribution Date.&rdquo; Until the Distribution Date, the common stock certificates, or,
in the case of uncertificated shares, notations in the book-entry account system, will also evidence the Rights, and any transfer
of shares of common stock will constitute a transfer of the corresponding Rights. After the Distribution Date, the Rights will
separate from the common stock and be evidenced by book-entry credits or by Rights certificates that the Company will mail to all
eligible holders of common stock. Any Rights held by an Acquiring Person are null and void and may not be exercised.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white"><I>Beneficial Ownership</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; background-color: white"><FONT STYLE="background-color: white">Certain
synthetic interests in securities created by derivative positions &mdash; whether or not such interests are considered to be ownership
of the underlying common stock or are reportable for purposes of Regulation 13D of the Securities Exchange Act of 1934, as amended
(the &ldquo;Exchange Act&rdquo;) &mdash; are treated as beneficial ownership of the number of shares of common stock equivalent
to the economic exposure created by the derivative position, to the extent actual shares of the common stock are directly or indirectly
held by counterparties to the derivatives </FONT></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; padding-bottom: 12pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><page></page></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="background-color: white">contracts.
Swaps dealers unassociated with any control intent or intent to evade the purposes of the stockholder rights plan are excepted
from such imputed beneficial ownership.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white"><I>Expiration</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; background-color: white"><FONT STYLE="background-color: white">The
Rights will expire on April 6, 2021.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white"><I>Redemption</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; background-color: white"><FONT STYLE="background-color: white">The
Board of Directors may redeem the Rights for $0.001 per Right at any time before any person or group becomes an Acquiring Person.
If the Board of Directors redeems any Rights, it must redeem all of the Rights. Once the Rights are redeemed, the only right of
the holders of Rights will be to receive the redemption price of $0.001 per</FONT> <FONT STYLE="background-color: white">Right. The redemption
price will be adjusted if there is a stock split of common stock or a dividend of common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white"><I>Anti-Dilution Provisions</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; background-color: white"><FONT STYLE="background-color: white">The
Board of Directors may adjust the purchase price of the Series A Preferred Shares, the number of Series A Preferred Shares issuable
and the number of outstanding Rights to prevent dilution that may occur from a stock dividend, a stock split, or a reclassification
of the Series A Preferred Shares or common stock. No adjustments to the Exercise Price of less than 1% will be made.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white"><I>Amendments</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 47.05pt; background-color: white">The terms of
the Rights Agreement may be amended by the Board of Directors without the consent of the holders of the Rights. After a person
or group becomes an Acquiring Person, the Board of Directors may not amend the Rights Agreement in a way that adversely affects
holders of the Rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 47.05pt; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><I>Consequences of a Person or Group
Becoming an Acquiring Person</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 18pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD><I>Flip In.</I> If a person or group becomes an Acquiring Person, all holders of Rights except the Acquiring Person may, for
the Exercise Price, purchase a number of shares of common stock with a market value of twice the Exercise Price, based on the market
value of common stock prior to such acquisition.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 18pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD><I>Exchange</I>. After a person or group becomes an Acquiring Person, but before an Acquiring Person owns 50% or more of the
outstanding shares of common stock, the Board of Directors may extinguish the Rights by exchanging one share of common stock or
an equivalent security for each Right, other than Rights held by the Acquiring Person.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 18pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD><I>Flip Over</I>. If the Company is later acquired in a merger or similar transaction after the Distribution Date, all holders
of Rights except the Acquiring Person may, for the Exercise Price, purchase a number of shares of the acquiring corporation with
a market value of twice the Exercise Price, based on the market value of the acquiring corporation&rsquo;s stock prior to such
transaction</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white"><I>Series A Preferred
Share Provisions</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="background-color: white">Each
one one-hundredth of a Series A Preferred Share, if issued:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 18pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD><FONT STYLE="background-color: white">will not be redeemable;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 18pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>will entitle its holder to quarterly dividend payments of $0.01 per share, or an amount equal to the dividend paid on one share
of common stock, whichever is greater;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 18pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD><FONT STYLE="background-color: white">will entitle its holder upon liquidation either to receive $1.00 per share or an amount
equal to the payment made on one share of common stock, whichever is greater;</FONT></TD></TR></TABLE>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; padding-bottom: 12pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><page></page></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 18pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD><FONT STYLE="background-color: white">will have the same voting power as one share of common stock; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 18pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD><FONT STYLE="background-color: white">if shares of common stock are exchanged via merger, consolidation, or a similar transaction,
will entitle holders to a per share payment equal to the payment made on one share of common stock.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt"><FONT STYLE="background-color: white">The value of
one one-hundredth interest in a Series A Preferred Share should approximate the value of one share of common stock</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Anti-Takeover Effects of Provisions of Delaware Law and
the Company&rsquo;s Certificate of Incorporation and Bylaws</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Section 203 of the Delaware General Corporation Law</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">The Company is a Delaware corporation and
is subject to Section 203 of the Delaware General Corporation Law (the &ldquo;DGCL&rdquo;). In general, Section 203 of the DGCL
prevents a public Delaware corporation from engaging in any &ldquo;business combination&rdquo; (as defined below) with an &ldquo;interested
stockholder&rdquo; (defined as a person who, together with affiliates and associates, beneficially owns (or within the preceding
three years, did beneficially own) 15% or more of a corporation&rsquo;s outstanding voting stock) for a period of three years following
the time that such person became an interested stockholder, unless (i) before such person became an interested stockholder, the
board of directors of the corporation approved either the transaction in which the interested stockholder became an interested
stockholder or the business combination; (ii) upon consummation of the transaction that resulted in the interested stockholder
becoming an interested stockholder, the interested stockholder owned at least 85% of the voting stock of the corporation outstanding
at the time the transaction commenced (excluding shares owned by persons who are both officers and directors of the corporation
and shares held by certain employee stock plans); or (iii) on or after such time, the business combination is approved by the board
of directors and authorized at an annual or special meeting of stockholders, and not by written consent, by the affirmative vote
of the holders of at least 66 2/3% of the outstanding voting stock of the corporation that is not owned by the interested stockholder.
A &ldquo;business combination&rdquo; generally includes mergers, stock or asset sales involving 10% or more of the market value
of the corporation&rsquo;s assets or stock, certain stock transactions and other transactions resulting in a financial benefit
to the interested stockholder or an increase in the interested stockholder&rsquo;s proportionate share of any class or series of
a corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Certificate of Incorporation and Bylaws</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; background-color: white">The Company&rsquo;s
restated certificate of incorporation (&ldquo;Certificate of Incorporation&rdquo;) and Bylaws include anti-takeover provisions
that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>prohibit stockholders from taking action by written consent and do not permit stockholders to call a special meeting;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>authorize the Board of Directors, without further action by the stockholders, to issue shares of preferred stock in one or
more series, and with respect to each series, to fix the number of shares constituting that series, and establish the rights and
terms of that series;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>establish advance notice procedures for stockholders to submit proposals and nominations of candidates for election to the
Board of Directors to be brought before a stockholders meeting;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>allow the Company&rsquo;s directors to establish the size of the Board of Directors (so long as the Board of Directors consists
of at least three and no more than fifteen directors) and fill vacancies on the Board of Directors created by an increase in the
number of directors (subject to the rights of the holders of any series of preferred stock to elect additional directors under
specified circumstances);</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>do not provide stockholders cumulative voting rights with respect to director elections; and</TD></TR></TABLE>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; padding-bottom: 12pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><page></page></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>provide that the Company&rsquo;s Bylaws may be amended by the Board of Directors without stockholder approval, to the extent
permitted by law.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">Certain provisions of the Company&rsquo;s
Certificate of Incorporation and Bylaws may delay or discourage transactions involving an actual or potential change in the Company&rsquo;s
control or change in the Board of Directors or management, including transactions in which stockholders might otherwise receive
a premium for their shares of common stock or transactions that the Company&rsquo;s stockholders might otherwise deem to be in
their best interests. Therefore, these provisions could adversely affect the price of the common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">In addition, the Bylaws provide that unless
the Company consents in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware shall
be the sole and exclusive forum for (i) any derivative action or proceeding brought on behalf of the Company, (ii) any action asserting
a claim of breach of a fiduciary duty owed by any director, officer, stockholder, employee or agent of the Company to the Company
or the Company&rsquo;s stockholders, (iii) any action asserting a claim against the Company or any director, officer, stockholder,
employee or agent of the Company arising out of or relating to any provision of the DGCL or the Certificate of Incorporation or
Bylaws, or (iv) any action asserting a claim against the Company or any director, officer, stockholder, employee or agent of the
Company governed by the internal affairs doctrine of the State of Delaware; provided, however, that, in the event that the Court
of Chancery of the State of Delaware lacks subject matter jurisdiction over any such action or proceeding, the sole and exclusive
forum for such action or proceeding shall be another state or federal court located within the State of Delaware, in each such
case, subject to the court having personal jurisdiction over the indispensable parties named as defendants</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">Under the Bylaws, to the fullest extent permitted
by law, this exclusive forum provision will apply to state and federal law claims, including claims under the Exchange Act, or
the Securities Act of 1933, as amended, or the respective rules and regulations promulgated thereunder; provided, however, that
the Company&rsquo;s stockholders will not be deemed to have waived the Company&rsquo;s compliance with the federal securities laws
and the rules and regulations thereunder. The enforceability of similar choice of forum provisions in other companies&rsquo; bylaws
has been challenged in legal proceedings, and it is possible that, in connection with claims arising under federal securities laws,
a court could find the choice of forum provisions contained in the Company&rsquo;s Bylaws to be inapplicable or unenforceable.
Although we believe this provision benefits the Company by providing increased consistency in the application of Delaware law in
the types of lawsuits to which it applies, this provision may have the effect of discouraging lawsuits against the Company&rsquo;s
directors and officers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Authorized and Unissued Shares</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Company&rsquo;s authorized and unissued
shares of common stock are available for future issuance without stockholder approval except as may otherwise be required by applicable
stock exchange rules or Delaware law. The Company may issue additional shares for a variety of purposes, including future offerings
to raise additional capital, to fund acquisitions, and as employee and consultant compensation. The existence of authorized but
unissued shares of common stock could render more difficult, or discourage an attempt, to obtain control of the Company by means
of a proxy contest, tender offer, merger or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">The issuance of shares of preferred stock
by the Company could have certain anti-takeover effects under certain circumstances, and could enable the Board of Directors to
render more difficult or discourage an attempt to obtain control of the Company by means of a merger, tender offer, or other business
combination transaction directed at the Company by, among other things, placing shares of preferred stock with investors who might
align themselves with the Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><A NAME="x1_c101351a009"></A>PLAN OF
DISTRIBUTION</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">We may sell the securities being offered
hereby in one or more of the following ways from time to time:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>to underwriters or dealers for resale to the public or to institutional investors;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>directly to institutional investors;</TD></TR></TABLE>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; padding-bottom: 12pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><page></page></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>directly to a limited number of purchasers or to a single purchaser;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>through agents to the public or to institutional investors; or</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>through a combination of any of these methods of sale.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">If we use underwriters or dealers in the
sale, the securities will be acquired by the underwriters or dealers for their own account and may be resold from time to time
in one or more transactions, including:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>at a fixed price or prices, which may be changed from time to time;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>in &ldquo;at the market offerings&rdquo; within the meaning of Rule 415(a)(4) of the Securities Act;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>at prices related to such prevailing market prices; or</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>at negotiated prices.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">For each series of securities, the prospectus
supplement will set forth the terms of the offering of the securities, including:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>the initial public offering price;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>the method of distribution, including the names of any underwriters, dealers or agents;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>the purchase price of the securities;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>our net proceeds from the sale of the securities;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>any underwriting discounts, agency fees, or other compensation payable to underwriters or agents;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>any discounts or concessions allowed or reallowed or repaid to dealers; and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>the securities exchanges on which the securities will be listed, if any.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">If we use underwriters in the sale, they
will buy the securities for their own account. The underwriters may then resell the securities in one or more transactions at a
fixed public offering price or at varying prices determined at the time of sale or thereafter. The obligations of the underwriters
to purchase the securities will be subject to certain conditions. The underwriters will be obligated to purchase all the securities
offered if they purchase any securities. Any initial public offering price and any discounts or concessions allowed or re-allowed
or paid to dealers may be changed from time to time. In connection with an offering, underwriters and selling group members and
their affiliates may engage in transactions to stabilize, maintain or otherwise affect the market price of the securities in accordance
with applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">If we use dealers in the sale, we will sell
securities to such dealers as principals. The dealers may then resell the securities to the public at varying prices to be determined
by such dealers at the time of resale. If we use agents in the sale, they will use their reasonable best efforts to solicit purchases
for the period of their appointment. If we sell directly, no underwriters or agents would be involved. We are not making an offer
of securities in any jurisdiction that does not permit such an offer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">Underwriters, dealers and agents that participate
in the securities distribution may be deemed to be underwriters as defined in the Securities Act. Any discounts, commissions or
profit they receive when they resell the securities may be treated as underwriting discounts and commissions under the Securities
Act. We may have agreements with underwriters, dealers and agents to indemnify them against certain civil liabilities, including
certain liabilities under the Securities Act, or to contribute with respect to payments that they may be required to make.</P>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; padding-bottom: 12pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><page></page></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0pt">Underwriters, dealers and agents may engage
in transactions with, or perform services for, us or our subsidiaries in the ordinary course of their business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">We may authorize underwriters, dealers or
agents to solicit offers from certain institutions whereby the institutions contractually agree to purchase the securities from
us on a future date at a specific price. This type of contract may be made only with institutions that we specifically approve.
Such institutions could include banks, insurance companies, pension funds, investment companies and educational and charitable
institutions. The underwriters, dealers or agents will not be responsible for the validity or performance of these contracts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">The securities will be new issues of securities
with no established trading market, other than our common stock, which is listed on the New York Stock Exchange, and unless otherwise
specified in the applicable prospectus supplement, we will not list any series of the securities on any exchange. It has not presently
been established whether the underwriters, if any, of the securities will make a market in the securities. If the underwriters
make a market in the securities, such market making may be discontinued at any time without notice. No assurance can be given as
to the liquidity of the trading market for the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><A NAME="x1_c101351a010"></A>LEGAL MATTERS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">Unless otherwise specified in any prospectus
supplement, the validity of the securities offered by this prospectus will be passed upon for us by Wachtell, Lipton, Rosen&nbsp;&amp;
Katz, New York, New York, and for any underwriters or agents by counsel named in the applicable prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><A NAME="x1_c101351a011"></A>EXPERTS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">The consolidated financial statements of
Hexcel Corporation and subsidiaries appearing in Hexcel Corporation and subsidiaries&rsquo; Annual Report on Form 10-K for the
year ended December 31, 2020, including the schedule appearing therein, and the effectiveness of Hexcel Corporation and subsidiaries&rsquo;
internal control over financial reporting as of December 31, 2020, have been audited by Ernst&nbsp;&amp; Young LLP, independent
registered public accounting firm, as set forth in their respective reports thereon, included therein and incorporated herein by
reference<FONT STYLE="background-color: white"> in reliance upon such reports given on the authority of such firm as experts in
accounting and auditing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><A NAME="x1_c101351a012"></A>WHERE YOU
CAN FIND MORE INFORMATION</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">We file annual, quarterly and current reports,
proxy statements and other information with the SEC. The SEC maintains an Internet site that contains information we have filed
electronically with the SEC, which you can access over the Internet at www.sec.gov. <FONT STYLE="background-color: white">In addition,
documents filed with the SEC by us will be available free of charge by accessing our website at <I>www.hexcel.com</I> under the
heading Investor Relations, or, alternatively, by directing a request by telephone, mail or e-mail to Hexcel Corporation at Two
Stamford Plaza, 281 Tresser Boulevard, Stamford, Connecticut 06901, (203) 352-6826, or InvestorRelations@Hexcel.com. The web addresses
of the SEC and Hexcel are included as inactive textual references only. Except as specifically incorporated by reference into this
prospectus, information on those web sites is not part of this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">This prospectus is part of a registration
statement on Form S-3 that we have filed with the SEC relating to the securities being offered pursuant to this prospectus. As
permitted by SEC rules, this prospectus does not contain all the information we have included in the registration statement and
the accompanying exhibits and schedules we have filed with the SEC. You may refer to the registration statement, exhibits and schedules
for more information about us and the securities. The registration statement, exhibits and schedules are available at the SEC&rsquo;s
public reference room or through its Internet site.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">The SEC allows us to &ldquo;incorporate by
reference&rdquo; the information we have filed with it, which means that we can disclose important information to you by referring
you to those documents. The information we incorporate by reference is an important part of this prospectus, and later information
that we file with the SEC will automatically update and supersede this information. We incorporate by reference the following documents
into this prospectus:</P>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; padding-bottom: 12pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><page></page></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD><A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/717605/000156459021004881/hxl-10k_20201231.htm">our Annual Report on Form 10-K for the year ended December 31, 2020 filed with the SEC on February 9, 2021;</A></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD><A HREF="https://www.sec.gov/Archives/edgar/data/717605/000093041321000642/c100775_def14a.htm">the portions of our Definitive Proxy Statement on Schedule 14A, filed on March 25, 2021</A>, that are specifically incorporated
by reference into our Annual Report on Form 10-K for the year ended December 31, 2020;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>the descriptions of our common stock contained in our Registration Statements on Form 8-B dated March 31, 1983 and Form 8-A
dated November 3, 1987;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>our Current Reports on Form 8-K filed on <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/717605/000156459021002086/hxl-8k_20210125.htm">January 25, 2021</A> and <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/717605/000093041321000084/c101044_8k-ixbrl.htm">January 28, 2021</A> (other than the portions of those documents
furnished and not deemed to be filed).</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">We also incorporate by reference any future
filings we make with the SEC under Section 13(a), 13(c), 14 or 15(d) of the Exchange Act (excluding information deemed to be furnished
and not filed with the SEC) until the termination of this offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">You may request a copy of these filings,
other than an exhibit to these filings unless we have specifically incorporated that exhibit by reference into the filing, at no
cost, by writing or telephoning us at the following address:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">Hexcel Corporation<BR>
Two Stamford Plaza<BR>
281 Tresser Boulevard<BR>
Stamford, Connecticut 06901<BR>
Attention: Secretary<BR>
Telephone: (203) 969-0666</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">You should rely only on the information incorporated
by reference or provided in this prospectus and any prospectus supplement. We have not authorized anyone else to provide you with
different information. You should not assume that the information in this prospectus or any prospectus supplement is accurate as
of any date other than the date on the front of these documents.</P>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; padding-bottom: 12pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><page></page></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">PART II</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">INFORMATION NOT REQUIRED IN PROSPECTUS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Item 14. Other Expenses of Issuance and Distribution</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">The following table sets forth all expenses
payable by us in connection with the offering of the securities being registered, other than discounts and commissions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="width: 75%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(229,255,255)">
    <TD STYLE="width: 88%; font: 10pt Times New Roman, Times, Serif">Securities and Exchange Commission Registration Fee</td>
    <TD STYLE="width: 3%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 9%; text-align: center; font: 10pt Times New Roman, Times, Serif">$&nbsp;&nbsp;*</td></tr>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Printing Expenses</td>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">$**</td></tr>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(229,255,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Legal Fees and Expenses</td>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">$**</td></tr>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Accounting Fees and Expenses</td>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">$**</td></tr>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(229,255,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Blue Sky Fees and Expenses</td>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">$**</td></tr>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Trustee, Transfer Agent and Registrar Fees and Expenses</td>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">$**</td></tr>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(229,255,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Rating Agency Fees and Expenses</td>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">$**</td></tr>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Miscellaneous</td>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1px solid; font: 10pt Times New Roman, Times, Serif; text-align: center">$**</td></tr>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(229,255,255)">
    <TD STYLE="padding-bottom: 2px; font: 10pt Times New Roman, Times, Serif">Total</td>
    <TD STYLE="padding-bottom: 2px; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 3px double; font: 10pt Times New Roman, Times, Serif; text-align: center">$**</td></tr>
</table>
<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1px solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">*&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred pursuant to Rule 456(b) under the Securities Act
and calculated in connection with an offering of securities under this registration statement pursuant to Rule 457(r) under the
Securities Act.</P>

<P STYLE="font: 3pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">**&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;These fees cannot be estimated at this time as they are
calculated based on the securities offered and the number of issuances. An estimate of the aggregate expenses in connection with
the sale and distribution of the securities being offered will be included in the applicable prospectus supplement.</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Item 15. Indemnification of Officers and Directors</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">Set forth below is a description of certain
provisions of the DGCL and the Certificate of Incorporation of the Company, as such provisions relate to the indemnification of
the directors and officers of the Company. This description is intended only as a summary and is qualified in its entirety by reference
to the applicable provisions of the DGCL, the Certificate of Incorporation of the Company, the Bylaws of the Company and the indemnification
agreements entered into by the Company and its directors and executive officers, which are incorporated herein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">Section 145 of the DGCL provides that a Delaware
corporation has the power to indemnify any person who was or is a party or is threatened to be made a party to any threatened,
pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (other than an action
by or in the right of the corporation) by reason of the fact that the person is or was a director, officer, employee or agent of
the corporation, or is or was serving at the request of the corporation in such capacity in another corporation, partnership, joint
venture, trust or other enterprise, against expenses (including attorneys&rsquo; fees), judgments, fines and amounts paid in settlement
actually and reasonably incurred by the person in connection with such action, suit or proceeding if the person acted in good faith
and in a manner the person reasonably believed to be in or not opposed to the best interests of the corporation, and, with respect
to any criminal action or proceeding, had no reasonable cause to believe the person&rsquo;s conduct was unlawful. In the case of
an action or suit brought by or in the right of the corporation, indemnification of any director, officer, employee or agent of
the corporation (or person serving at the request of the corporation in such capacity in another enterprise) against expenses actually
and reasonably incurred by such person in connection with the defense or settlement of such action or suit is permitted if such
person acted in good faith and in a manner the person reasonably believed to be in or not opposed to the best interests of the
corporation; however, no indemnification is permitted in respect of any claim, issue or matter as to which such person shall have
been adjudged to be liable to the corporation, unless and only to the extent that the Delaware Court of Chancery, or the court
in which such action or suit was brought, shall determine upon application that, despite the adjudication of liability but in view
of all the circumstances of the case, such person is fairly and reasonably entitled to indemnity for such expenses which the Delaware
Court of Chancery or such other court shall deem proper.</P>

<!-- Field: Page; Sequence: 20; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; padding-bottom: 12pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><page></page></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">The Company&rsquo;s Certificate of Incorporation
provides that the Company shall, to the fullest extent authorized or permitted by the DGCL, (i) indemnify its directors and officers
from and against any and all expenses (including attorneys&rsquo; fees), liabilities and other matters and (ii) advance expenses
(including attorneys&rsquo; fees) incurred by any and all of its directors and officers in connection with any threatened, pending
or completed action, suit or proceeding, whether civil, criminal, administrative or investigative; provided, however, that, except
for proceedings to enforce rights to indemnification, the Company shall not be obligated to indemnify any director or officer in
connection with a proceeding (or part thereof) initiated by such person unless such proceeding (or part thereof) was authorized
by the Board of Directors of the Company. The Company has entered into indemnification agreements with its executive officers and
directors which would require it, among other things, to indemnify them against certain liabilities which may arise by reason of
their status or service as a director or officer and to advance to them expenses, subject to reimbursement to the Company if it
is determined that they are not entitled to indemnification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">Section 102(b)(7) of the DGCL permits a corporation
to provide in its certificate of incorporation that a director of the corporation shall not be personally liable to the corporation
or its stockholders for monetary damages for breach of fiduciary duty as a director, except for liability (i) for any breach of
the director&rsquo;s duty of loyalty to the corporation or its stockholders, (ii) for acts or omissions not in good faith or which
involve intentional misconduct or a knowing violation of law, (iii) for unlawful payments of dividends or unlawful stock repurchases,
redemptions or other distributions or (iv) for any transaction from which the director derived an improper personal benefit. The
Company&rsquo;s Certificate of Incorporation eliminates the personal liability of a director to the fullest extent authorized or
permitted by the DGCL.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">Under the DGCL, a Delaware corporation has
the power to purchase and maintain insurance on behalf of any person who is or was director, officer, employee or agent of the
corporation or is or was serving in such capacity at the request of the corporation for another enterprise, against any liability
asserted against such person and incurred by such person in any such capacity, or arising out of such person&rsquo;s status as
such, whether or not the corporation would have the power to indemnify such person against such liability under the Section 145
of the DGCL. The Company maintains, at its expense, an insurance policy that insures the directors and officers of the Company,
subject to certain exclusions and deductions, against certain liabilities that they may incur in their capacity as such.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Item 16. Exhibits</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">A list of exhibits filed with this registration
statement is contained in the index to exhibits beginning on page II-5, which is incorporated by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Item 17. Undertakings</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 36pt; text-align: left">(a)</TD><TD STYLE="text-align: justify">The undersigned registrant hereby undertakes:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 36pt">(1)</TD><TD>To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 36pt">(i)</TD><TD>To include any prospectus required by Section 10(a)(3) of the Securities Act;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 36pt">(ii)</TD><TD>To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most
recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information
set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered
(if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or
high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the SEC pursuant to Rule
424(b) if, in the aggregate, the changes in volume and price represent no more than 20% change in the maximum aggregate offering
price set forth in the &ldquo;Calculation of Registration Fee&rdquo; table in the effective registration statement;</TD></TR></TABLE>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; padding-bottom: 12pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><page></page></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 36pt">(iii)</TD><TD>To include any material information with respect to the plan of distribution not previously disclosed in the registration statement
or any material change to such information in the registration statement;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt">provided, however, that paragraphs (a)(1)(i), (a)(1)(ii)
and (a)(1)(iii) above do not apply if the information required to be included in a post-effective amendment by those paragraphs
is contained in reports filed with or furnished to the SEC by the registrant pursuant to section 13 or section 15(d) of the Exchange
Act that are incorporated by reference in this registration statement, or is contained in a form of prospectus filed pursuant to
Rule 424(b) that is part of the registration statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 72pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 36pt">(2)</TD><TD>That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed
to be a new registration statement relating to the securities offered herein, and the offering of such securities at that time
shall be deemed to be the initial <I>bona fide</I> offering thereof.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 36pt">(3)</TD><TD>To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold
at the termination of the offering.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 36pt">(4)</TD><TD>That, for the purpose of determining liability under the Securities Act to any purchaser:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(A) Each prospectus filed by the registrant pursuant to Rule
424(b)(3) shall be deemed to be part of the registration statement as of the date the filed prospectus was deemed part of and included
in the registration statement; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(B) Each prospectus required to be filed pursuant to Rule 424(b)(2),
(b)(5), or (b)(7) as part of a registration statement in reliance on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i),
(vii), or (x) for the purpose of providing the information required by section 10(a) of the Securities Act shall be deemed to be
part of and included in the registration statement as of the earlier of the date such form of prospectus is first used after effectiveness
or the date of the first contract of sale of securities in the offering described in the prospectus. As provided in Rule 430B,
for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new
effective date of the registration statement relating to the securities in the registration statement to which that prospectus
relates, and the offering of such securities at that time shall be deemed to be the initial <I>bona fide </I>offering thereof.
<I>Provided</I>, <I>however</I>, that no statement made in a registration statement or prospectus that is part of the registration
statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus
that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective date,
supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement
or made in any such document immediately prior to such effective date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 36pt">(5)</TD><TD>That, for the purpose of determining liability of the registrant under the Securities Act to any purchaser in the initial distribution
of the securities, the undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant
pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if
the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant
will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 36pt">(i)</TD><TD>Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant
to Rule 424;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 36pt">(ii)</TD><TD>Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred
to by the undersigned registrant;</TD></TR></TABLE>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; padding-bottom: 12pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><page></page></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 36pt">(iii)</TD><TD>The portion of any other free writing prospectus relating to the offering containing material information about the undersigned
registrant or its securities provided by or on behalf of the undersigned registrant; and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 72pt"></TD><TD STYLE="width: 36pt">(iv)</TD><TD>Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(b)&#9;The undersigned registrant hereby further undertakes
that, for purposes of determining any liability under the Securities Act, each filing of the registrant&rsquo;s annual report pursuant
to Section 13(a) or Section 15(d) of the Exchange Act that is incorporated by reference in the registration statement shall be
deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that
time shall be deemed to be the initial <I>bona fide</I> offering thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(c)&#9;Insofar as indemnification for liabilities arising under
the Securities Act may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing
provisions, or otherwise, the registrant has been advised that in the opinion of the SEC such indemnification is against public
policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against
such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person
of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling
person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter
has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification
by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.</P>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; padding-bottom: 12pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><page></page></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">EXHIBIT INDEX</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <TD STYLE="width: 10%; text-align: center; border-bottom: Black 1px solid"><b>Exhibit</b><br>
<b>No.</b></td>
    <TD STYLE="width: 3%; padding-bottom: 1px">&nbsp;</TD>
    <TD STYLE="width: 87%; text-align: center; border-bottom: Black 1px solid"><b>Description of Document</b></td></tr>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<tr style="vertical-align: top">
    <TD>1.1*</td>
    <TD>&nbsp;</TD>
    <TD>Form of Underwriting Agreement</td></tr>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<tr style="vertical-align: top">
    <TD>3.1</td>
    <TD>&nbsp;</TD>
    <TD><A HREF="http://www.sec.gov/Archives/edgar/data/717605/000091205796014127/0000912057-96-014127.txt" STYLE="-sec-extract: exhibit">Restated Certificate of Incorporation of Hexcel Corporation (incorporated by reference to Exhibit 1 to the Company&rsquo;s Registration Statement on Form 8-A dated July 9, 1996, Registration No. 1-08472)</A></td></tr>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<tr style="vertical-align: top">
    <TD>3.2</td>
    <TD>&nbsp;</TD>
    <TD><A HREF="http://www.sec.gov/Archives/edgar/data/717605/000104746903011238/a2106961zex-3_2.txt" STYLE="-sec-extract: exhibit">Certificate of Amendment of the Restated Certificate of Incorporation of Hexcel Corporation (incorporated by reference to Exhibit 3.2 to the Company&rsquo;s Annual Report on Form 10-K/A for the fiscal year ended December 31, 2002, filed on March 31, 2003)</A></td></tr>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<tr style="vertical-align: top">
    <TD>3.3</td>
    <TD>&nbsp;</TD>
    <TD><A HREF="http://www.sec.gov/Archives/edgar/data/717605/000119312514349510/d793175dex3.htm" STYLE="-sec-extract: exhibit">Amended and Restated Bylaws of Hexcel Corporation (incorporated by reference to Exhibit 3 to the Company&rsquo;s Current Report on Form 8-K dated September 23, 2014)</A></td></tr>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<tr style="vertical-align: top">
    <TD>4.1</td>
    <TD>&nbsp;</TD>
    <TD><A HREF="http://www.sec.gov/Archives/edgar/data/717605/000119312515274802/d95488dex41.htm" STYLE="-sec-extract: exhibit">Indenture, dated as of August &nbsp;3, 2015, between Hexcel Corporation and U.S. Bank National Association, as Trustee (incorporated by reference to Exhibit 4.1 to the Company&rsquo;s Current Report on Form 8-K dated August 3, 2015)</A></td></tr>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<tr style="vertical-align: top">
    <TD>4.2*</td>
    <TD>&nbsp;</TD>
    <TD>Form of Debt Securities</td></tr>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<tr style="vertical-align: top">
    <TD>4.3*</td>
    <TD>&nbsp;</TD>
    <TD>Form of Preferred Stock Certificate</td></tr>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<tr style="vertical-align: top">
    <TD>5.1</td>
    <TD>&nbsp;</TD>
    <TD><A HREF="c101351_ex5-1.htm" STYLE="-sec-extract: exhibit">Opinion of Wachtell, Lipton, Rosen&nbsp;&amp; Katz</A></td></tr>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<tr style="vertical-align: top">
    <TD>23.1</td>
    <TD>&nbsp;</TD>
    <TD><A HREF="c101351_ex5-1.htm" STYLE="-sec-extract: exhibit">Consent of Wachtell, Lipton, Rosen&nbsp;&amp; Katz (included in Exhibit 5.1)</A></td></tr>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<tr style="vertical-align: top">
    <TD>23.2</td>
    <TD>&nbsp;</TD>
    <TD><A HREF="c101351_ex23-2.htm" STYLE="-sec-extract: exhibit">Consent of Ernst&nbsp;&amp; Young LLP</A></td></tr>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<tr style="vertical-align: top">
    <TD>24.1</td>
    <TD>&nbsp;</TD>
    <TD><a href="#pofatt">Power of Attorney (included on the signature page hereto)</a></td></tr>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<tr style="vertical-align: top">
    <TD>25.1</td>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><A HREF="c101351_ex25-1.htm" STYLE="-sec-extract: exhibit">Statement of Eligibility of Trustee on Form T-1 of U.S. Bank National Association</A></td></tr>
</table>
<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1px solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->



<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0">*&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To be filed by an amendment or an exhibit to a document
to be incorporated or deemed to be incorporated by reference to this registration statement, including a Current Report on Form
8-K.</P>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; padding-bottom: 12pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><page></page></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SIGNATURES</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">Pursuant to the requirements of the Securities
Act of 1933, Hexcel Corporation certifies that it has reasonable grounds to believe that it meets all of the requirements for filing
on Form S-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized,
in the City of Stamford, Connecticut, on March 26, 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <TD>&nbsp;</td>
    <td colspan="3">HEXCEL CORPORATION</td></tr>
<tr style="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</td>
    <TD STYLE="width: 6%">&nbsp;</td>
    <TD STYLE="width: 8%">&nbsp;</td>
    <TD STYLE="width: 36%">&nbsp;</td></tr>
<tr style="vertical-align: top">
    <TD STYLE="text-indent: 0pt; padding-bottom: 1px">&nbsp;</td>
    <TD STYLE="text-indent: 0pt; padding-bottom: 1px">By:</td>
    <TD STYLE="text-indent: 0pt; border-bottom: Black 1px solid">&nbsp;</td>
    <TD STYLE="text-indent: 0pt; border-bottom: Black 1px solid">/s/ Nick L. Stanage</td></tr>
<tr style="vertical-align: top">
    <TD STYLE="text-indent: 0pt">&nbsp;</td>
    <TD STYLE="text-indent: 0pt">&nbsp;</td>
    <TD STYLE="text-indent: 0pt">Name:</td>
    <TD STYLE="text-indent: 0pt">Nick L. Stanage</td></tr>
<tr style="vertical-align: top">
    <TD STYLE="text-indent: 0pt">&nbsp;</td>
    <TD STYLE="text-indent: 0pt">&nbsp;</td>
    <TD STYLE="text-indent: 0pt">Title:</td>
    <TD STYLE="text-indent: 0pt">Chairman of the Board of Directors,<br>
Chief Executive Officer and President</td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-weight: normal"><A NAME="pofatt"></A>POWER
OF ATTORNEY</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">Each person whose signature appears below
constitutes and appoints each of Nick L. Stanage, Patrick J. Winterlich and Gail E. Lehman and each or any of them (with full power
to act alone) as his or her true and lawful attorney-in-fact and agent, with full power of substitution and re-substitution, for
such person and in his or her name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective
amendments) to this registration statement, and to file the same, with all exhibits thereto, and other documents in connection
therewith, with the SEC, granting unto each attorney-in-fact and agent, full power and authority to do and perform each and every
act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he or she might
or could do in person, hereby ratifying and confirming all that each attorney-in-fact and agent, or his or her substitute or substitutes,
may lawfully do or cause to be done by virtue hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">Pursuant to the requirements of the Securities
Act of 1933, as amended, this registration statement has been signed by the following persons in the capacities and on the dates
indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 36pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
<tr style="vertical-align: bottom; background-color: Transparent">
    <TD NOWRAP STYLE="text-align: center; width: 26%"><B><I><U>Signature</U></I></B></td>
    <TD STYLE="width: 2%">&nbsp;</td>
    <TD NOWRAP STYLE="text-align: center; width: 50%"><B><I><U>Title</U></I></B></td>
    <TD STYLE="width: 2%">&nbsp;</td>
    <TD NOWRAP STYLE="text-align: center; width: 20%"><B><I><U>Date</U></I></B></td></tr>
<tr style="background-color: Transparent">
    <TD STYLE="text-align: center">&nbsp;</td>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></tr>
<tr style="background-color: Transparent">
    <TD STYLE="text-align: center; border-bottom: Black 1px solid">/s/ Nick L. Stanage</td>
    <TD STYLE="text-align: center; padding-bottom: 1px">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1px">Chairman of the Board of Directors, Chief Executive Officer and</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1px">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1px">March 26, 2021</TD></tr>
<tr style="background-color: Transparent">
    <TD STYLE="vertical-align: top; text-align: center">(Nick L. Stanage)</td>
    <TD STYLE="vertical-align: bottom">&nbsp;</td>
    <TD STYLE="vertical-align: top; text-align: center">President<br>
(Principal Executive Officer)</td>
    <TD STYLE="vertical-align: bottom">&nbsp;</td>
    <TD NOWRAP STYLE="vertical-align: top; text-align: center">&nbsp;</td></tr>
<tr style="background-color: Transparent">
    <TD STYLE="text-align: center">&nbsp;</td>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></tr>
<tr style="background-color: Transparent">
    <TD STYLE="vertical-align: top; text-align: center; border-bottom: Black 1px solid">/s/ Patrick J. Winterlich</td>
    <TD STYLE="vertical-align: bottom; padding-bottom: 1px">&nbsp;</td>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1px">Executive Vice President and</td>
    <TD STYLE="vertical-align: bottom; padding-bottom: 1px">&nbsp;</td>
    <TD NOWRAP STYLE="vertical-align: top; text-align: center; padding-bottom: 1px">March 26, 2021</td></tr>
<tr style="background-color: Transparent">
    <TD STYLE="vertical-align: top; text-align: center">(Patrick J. Winterlich)</td>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</td>
    <TD STYLE="vertical-align: top; text-align: center">Chief Financial Officer<br>
(Principal Financial Officer)</td>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</td>
    <TD NOWRAP STYLE="vertical-align: top; text-align: center">&nbsp;</td></tr>
<tr style="background-color: Transparent">
    <TD STYLE="text-align: center">&nbsp;</td>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></tr>
<tr style="background-color: Transparent">
    <TD STYLE="vertical-align: top; text-align: center; border-bottom: Black 1px solid">/s/ Amy S. Evans</td>
    <TD STYLE="vertical-align: bottom; padding-bottom: 1px">&nbsp;</td>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1px">Senior Vice President</td>
    <TD STYLE="vertical-align: bottom; padding-bottom: 1px">&nbsp;</td>
    <TD NOWRAP STYLE="vertical-align: top; text-align: center; padding-bottom: 1px">March 26, 2021</td></tr>
<tr style="background-color: Transparent">
    <TD STYLE="text-align: center">(Amy S. Evans)</td>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">and Chief Accounting Officer<br>
(Principal Accounting Officer)</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></tr>
<tr style="background-color: Transparent">
    <TD STYLE="text-align: center">&nbsp;</td>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></tr>
<tr style="background-color: Transparent">
    <TD STYLE="vertical-align: top; text-align: center; border-bottom: Black 1px solid">/s/ Jeffrey C. Campbell</td>
    <TD STYLE="vertical-align: bottom; padding-bottom: 1px">&nbsp;</td>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1px">Director</td>
    <TD STYLE="vertical-align: bottom; padding-bottom: 1px">&nbsp;</td>
    <TD NOWRAP STYLE="vertical-align: top; text-align: center; padding-bottom: 1px">March 26, 2021</td></tr>
<tr style="background-color: Transparent">
    <TD STYLE="text-align: center">(Jeffrey C. Campbell)</td>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></tr>
<tr style="background-color: Transparent">
    <TD STYLE="text-align: center">&nbsp;</td>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></tr>
<tr style="background-color: Transparent">
    <TD STYLE="vertical-align: top; text-align: center; border-bottom: Black 1px solid">/s/ Cynthia M. <br>
Egnotovich</td>
    <TD STYLE="vertical-align: bottom; padding-bottom: 1px">&nbsp;</td>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1px">Director</td>
    <TD STYLE="vertical-align: bottom; padding-bottom: 1px">&nbsp;</td>
    <TD NOWRAP STYLE="vertical-align: top; text-align: center; padding-bottom: 1px">March 26, 2021</td></tr>
<tr style="background-color: Transparent">
    <TD STYLE="text-align: center">(Cynthia M. Egnotovich)</td>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></tr>
<tr style="background-color: Transparent">
    <TD STYLE="text-align: center">&nbsp;</td>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></tr>
<tr style="background-color: Transparent">
    <TD STYLE="vertical-align: top; text-align: center; border-bottom: Black 1px solid">/s/ Thomas A. Gendron</td>
    <TD STYLE="vertical-align: bottom; padding-bottom: 1px">&nbsp;</td>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1px">Director</td>
    <TD STYLE="vertical-align: bottom; padding-bottom: 1px">&nbsp;</td>
    <TD NOWRAP STYLE="vertical-align: top; text-align: center; padding-bottom: 1px">March 26, 2021</td></tr>
<tr style="background-color: Transparent">
    <TD STYLE="text-align: center">(Thomas A. Gendron)</td>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></tr>
<tr style="background-color: Transparent">
    <TD STYLE="text-align: center">&nbsp;</td>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></tr>
<tr style="background-color: Transparent">
    <TD STYLE="vertical-align: top; text-align: center; border-bottom: Black 1px solid">/s/ Dr. Jeffrey A. Graves</td>
    <TD STYLE="vertical-align: bottom; padding-bottom: 1px">&nbsp;</td>
    <TD STYLE="vertical-align: top; text-align: center; padding-bottom: 1px">Director</td>
    <TD STYLE="vertical-align: bottom; padding-bottom: 1px">&nbsp;</td>
    <TD NOWRAP STYLE="vertical-align: top; text-align: center; padding-bottom: 1px">March 26, 2021</td></tr>
<tr style="background-color: Transparent">
    <TD STYLE="vertical-align: top; text-align: center">(Dr. Jeffrey A. Graves)</td>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</td>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</td>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</td>
    <TD NOWRAP STYLE="vertical-align: top; text-align: center">&nbsp;</td></tr>
</table>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; padding-bottom: 12pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><page></page></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
<tr style="background-color: Transparent">
    <TD STYLE="vertical-align: top; text-align: center; border-bottom: Black 1px solid; width: 26%">/s/ Guy C. Hachey</td>
    <TD STYLE="vertical-align: bottom; width: 2%">&nbsp;</td>
    <TD STYLE="vertical-align: top; text-align: center; width: 50%">Director</td>
    <TD STYLE="vertical-align: bottom; width: 2%">&nbsp;</td>
    <TD NOWRAP STYLE="vertical-align: top; text-align: center; width: 20%">March 26, 2021</td></tr>
<tr style="background-color: Transparent">
    <TD STYLE="vertical-align: top; text-align: center">(Guy C. Hachey)</td>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</td>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</td>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</td>
    <TD NOWRAP STYLE="vertical-align: top; text-align: center">&nbsp;</td></tr>
<tr style="background-color: Transparent">
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</td>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</td>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</td>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</td>
    <TD NOWRAP STYLE="vertical-align: top; text-align: center">&nbsp;</td></tr>
<tr style="background-color: Transparent">
    <TD STYLE="vertical-align: top; text-align: center; border-bottom: Black 1px solid">/s/ Dr. Marilyn L. Minus</td>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</td>
    <TD STYLE="vertical-align: top; text-align: center">Director</td>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</td>
    <TD NOWRAP STYLE="vertical-align: top; text-align: center">March 26, 2021</td></tr>
<tr style="background-color: Transparent">
    <TD STYLE="text-align: center">(Dr. Marilyn L. Minus)</td>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></tr>
<tr style="background-color: Transparent">
    <TD STYLE="text-align: center">&nbsp;</td>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></tr>
<tr style="background-color: Transparent">
    <TD STYLE="text-align: center; border-bottom: Black 1px solid">/s/ Catherine A. Suever</td>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">Director</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">March 26, 2021</TD></tr>
<tr style="background-color: Transparent">
    <TD STYLE="text-align: center">(Catherine A. Suever)</td>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></tr>
</table>
<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; padding-bottom: 12pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>x1_c101351x4x1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 x1_c101351x4x1.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !< 04# 2(  A$! Q$!_\0
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M"ZNQ(X)HC1G*/,M@<DG8]9HK@?B!\0+KP;?6=O;V,-P+B-G)D8C&#CM7'?\
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E(HT"1HH5548  Z 4ZO$J3<Y.3.E*RL%%%%0,**** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>c101351_ex5-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>Exhibit 5.1</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">[Letterhead of Wachtell, Lipton, Rosen &amp;
Katz]</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 4pt 0 12pt; text-align: center">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 4pt 0 12pt; text-align: center">March 26, 2021</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt"><A NAME="lblRe"></A>Hexcel Corporation<BR>
Two Stamford Plaza<BR>
281 Tresser Boulevard<BR>
Stamford, Connecticut 06901</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-weight: normal">Re:</FONT></TD><TD STYLE="padding-right: 1.5in"><A NAME="ReLine"></A>Registration Statement on Form S-3</TD></TR></TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt"><A NAME="Salutation"></A>Ladies and Gentlemen:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">We have acted as special outside counsel
to Hexcel Corporation, a Delaware corporation (the &ldquo;Company&rdquo;), in connection with the Registration Statement on Form
S-3 (the &ldquo;Registration Statement&rdquo;) to be filed on the date hereof with the Securities and Exchange Commission (the
&ldquo;SEC&rdquo;) in connection with the registration, pursuant to the Securities Act of 1933, as amended (including the rules
and regulations thereunder, the &ldquo;Act&rdquo;), that is automatically effective under the Act pursuant to Rule 462(e) promulgated
thereunder of an indeterminate amount of the Company&rsquo;s (a) debt securities (the &ldquo;Debt Securities&rdquo;); (b) preferred
stock (the &ldquo;Preferred Stock&rdquo;) and (c) common stock, par value $0.01 per share (the &ldquo;Common Stock&rdquo;). The
Debt Securities, the Preferred Stock and the Common Stock are collectively referred to herein as the &ldquo;Securities.&rdquo;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">The Debt Securities are to be issued
under an Indenture (the &ldquo;Indenture&rdquo;), dated as of August 3, 2015, between the Company and U.S. Bank National Association,
as Trustee, and filed as Exhibit 4.1 to the Registration Statement.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">The prospectus that is part of the Registration
Statement as supplemented in the future by various supplements to the prospectus (each, a &ldquo;Prospectus Supplement&rdquo;)
will provide for the issuance and sale by the Company of the Securities, which may be offered pursuant to Rule 415 under the Act.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">We have examined and relied on originals
or copies certified or otherwise identified to our satisfaction of such documents, corporate records, certificates of the Company
or public officials and other instruments as we have deemed necessary or appropriate for the purposes of this opinion letter. In
such examination, we have assumed (a) the authenticity of original documents and the genuineness of all signatures; (b) the conformity
to the originals of all documents submitted to us as copies; (c) the truth, accuracy and completeness of the information, representations
and warranties contained in the agreements, records, documents, instruments and certificates we have reviewed; (d) the Registration
Statement, and any amendments thereto (including post-effective amendments), are effective under the Act; (e) an appropriate Prospectus
Supplement or term sheet will have been filed with the SEC describing the Securities offered thereby; (f) all Securities will be
issued and sold in compliance with applicable federal and state securities laws and in the manner stated in the Registration Statement
and the applicable </P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Gray 4px solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">Hexcel Corporation</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">March 26, 2021</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">Page 2</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt">Prospectus Supplement(s); (g) a definitive purchase, underwriting, agency or similar agreement with respect
to any Securities offered will have been duly authorized and validly executed and delivered by the parties thereto; (h) any Debt
Securities that may be issued will be issued in a form that complies with the Indenture, and any supplemental indenture to be entered
into in connection with the issuance of such Debt Securities will be manually signed or countersigned, as the case may be, by duly
authorized officers of the Company and of the trustee named therein; and (i) at the time of any issuance of Common Stock or Securities
convertible into, exchangeable, redeemable or exercisable for Common Stock, there will be sufficient authorized but unissued shares
of Common Stock reserved for such issuance and any Securities issuable upon conversion, exchange, redemption or exercise of any
Securities being offered will be duly authorized and created. We have assumed that the terms of the Securities have been duly authorized
and created by the Company, and that the terms of the Securities have been established so as not to, and that the execution and
delivery by the parties thereto of the documents pursuant to which the Securities are governed and the performance of such parties&rsquo;
obligations thereunder, will not, breach, violate, conflict with or constitute a default under (1) the organizational documents
of any party or any agreement or instrument to which any party thereto is subject, (2) any law, rule or regulation to which any
party thereto is subject (excepting the laws of the State of New York, the General Corporation Law of the State of Delaware (the
&ldquo;DGCL&rdquo;) and the federal securities laws of the United States of America as such laws apply to the Company and the transaction
pursuant to which the Securities are offered), (3) any judicial or regulatory order or decree of any governmental authority or
(4) any consent, approval, license, authorization or validation of, or filing, recording or registration with any governmental
authority. We also assume that at the time of issuance of the Securities the Company is and will remain duly organized, validly
existing and in good standing under the laws of the State of Delaware and that the Company will have duly authorized the issuance
of the Securities and related matters. As to any facts material to the opinions expressed herein that we did not independently
establish or verify, we have relied and will rely upon statements and representations of officers and other representatives of
the Company and others.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">We are members of the Bar of the State
of New York, and we have not considered, and we express no opinion as to, the laws of any jurisdiction other than the laws of the
State of New York, the DGCL and the federal securities laws of the United States of America, in each case as in effect on the date
hereof.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Based upon the foregoing, and subject
to the qualifications set forth in this letter, we advise you that, in our opinion:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">1.</TD><TD>With respect to any series of Debt Securities to be offered by the Company pursuant to the Registration Statement (the &ldquo;Offered
Debt Securities&rdquo;), when (a) the Registration Statement, as finally amended (including all necessary post-effective amendments),
has become effective under the Act and the Indenture has been qualified under the Trust Indenture Act of 1939, as amended; (b)
an appropriate Prospectus Supplement or term sheet with respect to the Offered Debt Securities has been prepared, delivered and
filed in compliance with the Act; (c) the Indenture and </TD></TR></TABLE>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Gray 4px solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">Hexcel Corporation</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">March 26, 2021</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">Page 3</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"></TD><TD>any supplemental indenture to be entered into in connection
with the issuance of such Offered Debt Securities; and (e) the Offered Debt Securities have been duly authorized, executed and
delivered against payment of the agreed-upon consideration therefor, the Offered Debt Securities (including any Debt Securities
duly issued upon conversion, exchange or exercise of any Securities) when issued and sold in accordance with the Indenture, any
supplemental indenture to be entered into in connection with the issuance of such Offered Debt Securities and the purchase agreement,
will be valid and binding obligations of the Company, enforceable against the Company in accordance with their respective terms.</TD></TR></TABLE>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">2.</TD><TD>With respect to any shares of Preferred Stock to be offered by the Company pursuant to the Registration Statement (the &ldquo;Offered
Preferred Shares&rdquo;), when (a) the Registration Statement, as finally amended (including all necessary post-effective amendments),
has become effective under the Act; (b) an appropriate Prospectus Supplement or term sheet with respect to the Offered Preferred
Shares has been prepared, delivered and filed in compliance with the Act; (c) the adoption and filing with the Secretary of State
of the State of Delaware of a Certificate of Designation for the Offered Preferred Stock in accordance with the DGCL has duly occurred
and (d)&nbsp;if certificated, certificates in the form required under the DGCL representing the Offered Preferred Shares are duly
executed, countersigned, registered and delivered upon payment of the agreed upon consideration therefor, the Offered Preferred
Shares (including any shares of Preferred Stock duly issued upon conversion, exchange or exercise of any other Securities registered
on the Registration Statement), when issued and sold in accordance with the purchase agreement, will be legally issued, fully paid
and nonassessable.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">3.</TD><TD>With respect to any shares of Common Stock to be offered by the Company pursuant to the Registration Statement (the &ldquo;Offered
Common Shares&rdquo;), when (a)&nbsp;the Registration Statement, as finally amended (including all necessary post-effective amendments),
has become effective under the Act; (b) an appropriate Prospectus Supplement or term sheet with respect to the Offered Common Shares
has been prepared, delivered and filed in compliance with the Act; and (c) if certificated, certificates in the form required under
the DGCL representing the Offered Common Shares are duly executed, countersigned, registered and delivered upon payment of the
agreed upon consideration therefor, the Offered Common Shares (including any shares of Common Stock duly issued upon conversion,
exchange or exercise of any other Securities registered on the Registration Statement), when issued and sold in accordance with
the purchase agreement, will be legally issued, fully paid and nonassessable.</TD></TR></TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Gray 4px solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">Hexcel Corporation</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">March 26, 2021</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">Page 4</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">The opinions set forth above are subject
to the effects of (a) bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium and other similar laws relating
to or affecting the enforcement of creditors&rsquo; rights generally; (b) general equitable principles (whether considered in a
proceeding in equity or at law); (c) an implied covenant of good faith and fair dealing; (d) provisions of law that require that
a judgment for money damages rendered by a court in the United States be expressed only in United States dollars; (e) limitations
by any governmental authority that limit, delay or prohibit the making of payments outside the United States; and (f) generally
applicable laws that (1) provide for the enforcement of oral waivers or modifications where a material change of position in reliance
thereon has occurred or provide that a course of performance may operate as a waiver, (2) limit the availability of a remedy under
certain circumstances where another remedy has been elected, (3) limit the enforceability of provisions releasing, exculpating
or exempting a party from, or requiring indemnification of a party for, liability for its own action or inaction, to the extent
the action or inaction involves negligence, gross negligence, recklessness, willful misconduct or unlawful conduct, (4) may, where
less than all of a contract may be unenforceable, limit the enforceability of the balance of the contract to circumstances in which
the unenforceable portion is not an essential part of the agreed-upon exchange, (5) may limit the enforceability of provisions
providing for compounded interest, imposing increased interest rates or late payment charges upon delinquency in payment or default
or providing for liquidated damages or for premiums or penalties upon acceleration, or (6) limit the waiver of rights under usury
laws. Furthermore, the manner in which any particular issue relating to the opinions would be treated in any actual court case
would depend in part on facts and circumstances particular to the case and would also depend on how the court involved chose to
exercise the wide discretionary authority generally available to it. We express no opinion as to the effect of Section 210(p) of
the Dodd-Frank Wall Street Reform and Consumer Protection Act.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">We express no opinion as to whether,
or the extent to which, the laws of any particular jurisdiction apply to the subject matter hereof, including, without limitation,
the enforceability of the governing law provision contained in any Securities and their governing documents.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">This letter speaks only as of its date
and is delivered in accordance with the requirements of Item 601(b)(5) of Regulation S-K under the Act. We hereby consent to the
filing of copies of this opinion letter as an exhibit to the Registration Statement and to the use of our name in the prospectus
forming a part of the Registration Statement under the caption &ldquo;Legal Matters.&rdquo; In giving this consent, we do not thereby
admit that we are within the category of persons whose consent is required under Section 7 of the Act.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 3.5in"><A NAME="Closing"></A>Very truly yours,</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 3.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0.5in 3.5in">/s/ Wachtell, Lipton, Rosen &amp; Katz</P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Gray 4px solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 3.5in"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>4
<FILENAME>c101351_ex23-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: right"><B>Exhibit 23.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Consent of Independent Registered Public
Accounting Firm</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #333333">We consent to the reference to our firm under
the caption &ldquo;Experts&rdquo; in the Registration Statement (Form S-3) and related Prospectus of Hexcel Corporation for the
registration of debt securities, common stock, preferred stock and to the incorporation by reference therein of our reports dated&nbsp;February
9, 2021, with respect to the consolidated financial statements and schedule of Hexcel Corporation and subsidiaries,&nbsp;and the
effectiveness of internal control over financial reporting of Hexcel Corporation and subsidiaries, included in its Annual Report
on Form 10-K for the year ended December 31, 2020, filed with the Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #333333">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #333333">/s/ Ernst&nbsp;&amp; Young LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #333333">Stamford, Connecticut</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #333333">March 26, 2021</P>



<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Arial, Helvetica, Sans-Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->





<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-25.1
<SEQUENCE>5
<FILENAME>c101351_ex25-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Exhibit 25.1</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT"><DIV STYLE="font-size: 1pt; border-top: Black 1px solid; border-bottom: Black 1px solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 16pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-variant: small-caps"><B>securities
and exchange commission</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER"><DIV STYLE="font-size: 1pt; border-top: Black 1px solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 16pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM T-1</B></P>

<P STYLE="font: 16pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Statement
of Eligibility Under<BR>
The Trust Indenture Act of 1939 of a<BR>
Corporation Designated to Act as Trustee</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Check if an Application to Determine Eligibility
of<BR>
a Trustee Pursuant to Section 305(b)(2) &nbsp;&nbsp;&nbsp;<FONT STYLE="font-family: Wingdings">o</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER"><DIV STYLE="font-size: 1pt; border-top: Black 1px solid; width: 65%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>U.S. BANK NATIONAL ASSOCIATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of Trustee as specified in its
charter)</P>

<P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>31-0841368</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">I.R.S. Employer Identification No.</P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <TD STYLE="width: 50%; border: black 1px solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><font style="font-size: 10pt">800 Nicollet Mall</font><br>
<font style="font-size: 10pt">Minneapolis, Minnesota</font></td>
    <TD STYLE="width: 50%; border-top: black 1px solid; border-right: black 1px solid; border-bottom: black 1px solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><font style="font-size: 10pt">55402</font></td></tr>
<tr style="vertical-align: top">
    <TD STYLE="border-right: black 1px solid; border-bottom: black 1px solid; border-left: black 1px solid; font: 8pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 10pt">(Address
    of principal executive offices)</FONT></td>
    <TD STYLE="border-right: black 1px solid; border-bottom: black 1px solid; font: 8pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 10pt">(Zip
    Code)</FONT></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Kathy L. Mitchell<BR>
U.S. Bank National Association<BR>
185 Asylum Street, 27<SUP>th</SUP> Floor<BR>
Hartford, CT 06103<BR>
(860)241-6832</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Name, address and telephone number of agent
for service)</P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Hexcel Corporation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Issuer with respect to the Securities)</P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-family: Times New Roman, Times, Serif">
<tr style="vertical-align: top">
    <TD STYLE="width: 50%; border: black 1px solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 12pt; text-align: center">Delaware</td>
    <TD STYLE="width: 50%; border-top: black 1px solid; border-right: black 1px solid; border-bottom: black 1px solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 12pt; text-align: center">94-1109521</td></tr>
<TR STYLE="vertical-align: top; font-size: 10pt">
    <TD STYLE="border-right: black 1px solid; border-bottom: black 1px solid; border-left: black 1px solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center">(State
    or other jurisdiction of incorporation or organization)</td>
    <TD STYLE="border-right: black 1px solid; border-bottom: black 1px solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center">(I.R.S.
    Employer Identification No.)</td></tr>
<tr style="vertical-align: top">
    <TD STYLE="border-right: black 1px solid; border-bottom: black 1px solid; border-left: black 1px solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 8pt">&nbsp;</td>
    <TD STYLE="border-right: black 1px solid; border-bottom: black 1px solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 8pt; text-align: center">&nbsp;</td></tr>
</table>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-family: Times New Roman, Times, Serif">
<tr style="vertical-align: top">
    <TD STYLE="width: 50%; border: black 1px solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 12pt; text-align: center">Two Stamford Plaza<br>
281 Tresser Boulevard<br>
Stamford, CT&nbsp;&nbsp;</td>
    <TD STYLE="width: 50%; border-top: black 1px solid; border-right: black 1px solid; border-bottom: black 1px solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 12pt; text-align: center; vertical-align: bottom">06901-3238</td></tr>
<tr style="vertical-align: top">
    <TD STYLE="border-right: black 1px solid; border-bottom: black 1px solid; border-left: black 1px solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 8pt; text-align: center"><FONT STYLE="font-size: 10pt">(Address
    of Principal Executive Offices)</FONT></td>
    <TD STYLE="border-right: black 1px solid; border-bottom: black 1px solid; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 8pt; text-align: center"><FONT STYLE="font-size: 10pt">(Zip
    Code)</FONT></td></tr>
</table>
<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Debt Securities</B></P>

<P STYLE="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: center; text-indent: -103.5pt"><B>(Title
of the Indenture Securities)</B></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Arial, Helvetica, Sans-Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><PAGE></PAGE></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>FORM T-1</U></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-family: Times New Roman, Times, Serif">
<tr style="vertical-align: top">
    <TD STYLE="width: 12%; font-size: 12pt"><b>Item 1.</b></td>
    <TD STYLE="width: 88%; font-size: 12pt"><b>GENERAL INFORMATION<i>.</i></b>&nbsp;&nbsp;Furnish the following information as to the Trustee.</td></tr>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 12pt">&nbsp;</TD>
    <TD STYLE="font-size: 12pt">&nbsp;</TD></TR>
</table>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-family: Times New Roman, Times, Serif">
<tr style="vertical-align: top">
    <TD STYLE="width: 12%; font-size: 12pt">&nbsp;</td>
    <TD STYLE="width: 5%; font-size: 12pt">a)</td>
    <TD STYLE="width: 83%; font-size: 12pt"><i>Name and address of each examining or supervising authority to which it is subject.</i></td></tr>
</table>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-family: Times New Roman, Times, Serif">
<tr style="vertical-align: top">
    <TD STYLE="width: 10%; font-size: 12pt">&nbsp;</td>
    <TD STYLE="width: 10%; font-size: 12pt">&nbsp;</td>
    <TD STYLE="width: 80%; font-size: 12pt">Comptroller of the Currency</td></tr>
<tr style="vertical-align: top">
    <TD STYLE="font-size: 12pt">&nbsp;</td>
    <TD STYLE="font-size: 12pt">&nbsp;</td>
    <TD STYLE="font-size: 12pt">Washington, D.C.</td></tr>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 12pt">&nbsp;</TD>
    <TD STYLE="font-size: 12pt">&nbsp;</TD>
    <TD STYLE="font-size: 12pt">&nbsp;</TD></TR>
</table>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-family: Times New Roman, Times, Serif">
<tr style="vertical-align: top">
    <TD STYLE="width: 12%; font-size: 12pt">&nbsp;</td>
    <TD STYLE="width: 5%; font-size: 12pt">b)</td>
    <TD STYLE="width: 83%; font-size: 12pt"><i>Whether it is authorized to exercise corporate trust powers.</i> </td></tr>
</table>
<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-family: Times New Roman, Times, Serif">
<tr style="vertical-align: top">
    <td style="width: 88%; font-size: 12pt">&nbsp;</td>
    <td style="width: 12%; font-size: 12pt">Yes</td></tr>
</table>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-family: Times New Roman, Times, Serif">
<tr style="vertical-align: top">
    <TD STYLE="width: 12%; font-size: 12pt"><b>Item 2.</b></td>
    <TD STYLE="width: 88%; font-size: 12pt"><b>AFFILIATIONS WITH THE OBLIGOR. <i>&nbsp;</i></b><i>If the obligor is an affiliate of the Trustee, describe each such affiliation.</i></td></tr>
</table>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 10%"></TD><TD STYLE="width: 5%"></TD><TD STYLE="width: 85%">None</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 12pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-family: Times New Roman, Times, Serif">
<tr style="vertical-align: top">
    <TD STYLE="width: 12%; font-size: 12pt"><b>Items 3-15</b></td>
    <TD STYLE="width: 88%; font-size: 12pt"><i>Items 3-15 are not applicable because to the best of the Trustee's knowledge, the obligor is not in default under any Indenture for which the Trustee acts as Trustee.</i></td></tr>
</table>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.35in"></TD><TD></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 12pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-family: Times New Roman, Times, Serif">
<tr style="vertical-align: top">
    <TD STYLE="width: 12%; font-size: 12pt"><b>Item 16.</b></td>
    <TD STYLE="width: 88%; font-size: 12pt"><b>LIST OF EXHIBITS:</b> <i>&nbsp;List below all exhibits filed as a part of this statement of eligibility and qualification. </i></td></tr>
</table>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-align: left; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-align: left; text-indent: 0in">&nbsp;</TD></TR>
<tr style="vertical-align: top">
    <TD STYLE="width: 12%; text-align: left; text-indent: 0in">&nbsp;</td>
    <TD STYLE="width: 5%; text-align: left; text-indent: 0in"><font style="font-size: 12pt">1.</font></td>
    <TD STYLE="width: 83%; text-align: left; text-indent: 0in"><font style="font-size: 12pt">A copy of the Articles of Association of the Trustee.*</font></td></tr>
<tr style="vertical-align: top">
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td></tr>
<tr style="vertical-align: top">
    <TD>&nbsp;</td>
    <TD>2.</td>
    <TD>A copy of the certificate of authority of the Trustee to commence business, attached as Exhibit 2.</td></tr>
<tr style="vertical-align: top">
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td></tr>
<tr style="vertical-align: top">
    <TD>&nbsp;</td>
    <TD>3.</td>
    <TD>A copy of the certificate of authority of the Trustee to exercise corporate trust powers, attached as Exhibit 3.</td></tr>
<tr style="vertical-align: top">
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td></tr>
<tr style="vertical-align: top">
    <TD>&nbsp;</td>
    <TD>4.</td>
    <TD>A copy of the existing bylaws of the Trustee.**</td></tr>
<tr style="vertical-align: top">
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td></tr>
<tr style="vertical-align: top">
    <TD>&nbsp;</td>
    <TD>5.</td>
    <TD>A copy of each Indenture referred to in Item 4.&nbsp;&nbsp;Not applicable.</td></tr>
<tr style="vertical-align: top">
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td></tr>
<tr style="vertical-align: top">
    <TD>&nbsp;</td>
    <TD>6.</td>
    <TD>The consent of the Trustee required by Section 321(b) of the Trust Indenture Act of 1939, attached as Exhibit 6.</td></tr>
<tr style="vertical-align: top">
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>&nbsp;</td></tr>
<tr style="vertical-align: top">
    <TD>&nbsp;</td>
    <TD>7.</td>
    <TD>Report of Condition of the Trustee as of December 31, 2020 published pursuant to law or the requirements of its supervising or examining authority, attached as Exhibit 7.</td></tr>
</table>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<tr style="vertical-align: top">
    <TD STYLE="width: 5%">&nbsp;</td>
    <TD STYLE="width: 95%">* Incorporated by reference to Exhibit 25.1 to Amendment No. 2 to registration statement on S-4, Registration Number 333-128217 filed on November 15, 2005.</td></tr>
<tr style="vertical-align: top">
    <TD>&nbsp;</td>
    <TD>&nbsp;</td></tr>
<tr style="vertical-align: top">
    <TD>&nbsp;</td>
    <TD>** Incorporated by reference to Exhibit 25.1 to registration statement on form S-3ASR, &nbsp;Registration Number 333-199863 filed on November 5, 2014.</td></tr>
</table>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; padding-bottom: 12pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><PAGE></PAGE></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURE</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to the requirements of the Trust
Indenture Act of 1939, as amended, the Trustee, U.S. BANK NATIONAL ASSOCIATION<FONT STYLE="font-size: 10pt">, </FONT>a national
banking association organized and existing under the laws of the United States of America, has duly caused this statement of eligibility
and qualification to be signed on its behalf by the undersigned, thereunto duly authorized, all in the City of Hartford, State
of Connecticut on the 18<SUP>th</SUP> day of March, 2021.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</td>
    <TD STYLE="width: 4%">By:</td>
    <TD STYLE="width: 25%; border-bottom: Black 1px solid">/s/ Kathy L. Mitchell</td>
    <TD STYLE="width: 21%">&nbsp;</td></tr>
<tr style="vertical-align: top">
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>Kathy L. Mitchell</td>
    <TD>&nbsp;</td></tr>
<tr style="vertical-align: top">
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>Vice President</td>
    <TD>&nbsp;</td></tr>
</table>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; padding-bottom: 12pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><PAGE></PAGE></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Exhibit 2</U></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<DIV STYLE="border: Black 1px solid; padding: 5pt; text-align: center">

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top; background-color: white">
    <TD ROWSPAN="2" STYLE="width: 5%; font: 10pt Arial, Helvetica, Sans-Serif; text-indent: 0in; color: #464750"><IMG SRC="x1_c101351a001.jpg" ALT=""></td>
    <TD STYLE="width: 95%; font: 10pt Arial, Helvetica, Sans-Serif; color: #464750; padding-top: 20pt; border-bottom: Black 1px solid"><font style="font-size: 10pt">Office of the Comptroller of the Currency</font></td></tr>
<tr style="vertical-align: top; background-color: white">
    <TD STYLE="font: 8pt Arial, Helvetica, Sans-Serif; text-align: right; color: #797778"><font style="font-size: 8pt">Washington. DC 20219</font></td></tr>
</table>
<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: transparent">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: transparent"><B>CERTIFICATE
<FONT STYLE="color: #2F0012">OF </FONT>CORPORATE EXISTENCE</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: transparent">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: black">I, </FONT>Brian
Brooks, Acting Comptroller of the Currency, do hereby certify <FONT STYLE="color: #464750">that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: #464750">1. </FONT>The
Comptroller of the Currency, pursuant to Revised Statutes 324, et seq, as amended, and 12 USC <FONT STYLE="color: #464750">1, </FONT>et
seq, as amended, has possession, custody, and control of all records pertaining <FONT STYLE="color: #464750">to </FONT><FONT STYLE="color: #2F0012">the
</FONT>chartering, regulation, and supervision of all national banking associations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: #464750">2. </FONT>&ldquo;U.S.
Bank National Association,&rdquo; Cincinnati, Ohio (Charter No. <FONT STYLE="color: #464750">24), </FONT>is <FONT STYLE="color: #464750">a
</FONT>national banking association formed under the laws of the United States and is authorized thereunder to transact the business
of banking on the date of this certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">IN TESTIMONY WHEREOF, today, December <FONT STYLE="color: #365F85">4, </FONT>2020,
I<FONT STYLE="color: #2F0012"> </FONT>have hereunto subscribed my name and caused my seal of office to be affixed to these
presents <FONT STYLE="color: #464750">at </FONT>the <FONT STYLE="color: #464750">U.S. </FONT>Department of the Treasury, in
the City of Washington, District of Columbia</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="background-color: white">
    <TD STYLE="vertical-align: top; width: 30%; font-size: 9.5pt; color: #333042">&nbsp;</td>
    <TD STYLE="vertical-align: bottom; width: 40%; font-size: 9.5pt; color: #333042; text-align: center; border-bottom: Black 1px solid"><IMG SRC="x1_c101351a003.jpg" ALT=""></td>
    <TD STYLE="vertical-align: top; width: 30%; font-size: 9.5pt; color: #333042">&nbsp;</td></tr>
<tr style="background-color: white">
    <TD STYLE="vertical-align: top; font-size: 9.5pt; color: #333042">&nbsp;</td>
    <TD STYLE="vertical-align: bottom; font-size: 9.5pt; color: #333042; text-align: center">Acting Comptroller of the Currency</td>
    <TD STYLE="vertical-align: top; font-size: 9.5pt; color: #333042">&nbsp;</td></tr>
</table>

<P STYLE="font: 9pt Sans-Serif; margin: 0pt 0; color: Red">&nbsp;</P>

<P STYLE="font: 9pt Sans-Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt; color: Red"><IMG SRC="x1_c101351a002.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 9pt Sans-Serif; margin: 0pt 0; color: Red">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">2021-00217-C</P>
</div>
<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; padding-bottom: 12pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><PAGE></PAGE></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center;"><U>Exhibit
3</U></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center;">&nbsp;</P>

<DIV STYLE="border: Black 1px solid; padding: 5pt; text-align: center">
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top; background-color: white">
    <TD ROWSPAN="2" STYLE="width: 5%; font: 10pt Arial, Helvetica, Sans-Serif; text-indent: 0in; color: #464750"><IMG SRC="x1_c101351a001.jpg" ALT=""></td>
    <TD STYLE="width: 95%; font: 10pt Arial, Helvetica, Sans-Serif; color: #464750; text-align: left; vertical-align: bottom; padding-top: 20pt; border-bottom: Black 1px solid"><font style="font-size: 10pt">Office of the Comptroller of the Currency</font></td></tr>
<tr style="vertical-align: top; background-color: white">
    <TD STYLE="font: 8pt Arial, Helvetica, Sans-Serif; text-align: right; color: #797778"><font style="font-size: 8pt; color: #464750">Washington, DC 20219</font></td></tr>
</table>
<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: transparent">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: transparent"><FONT STYLE="color: #281D2F">CERTIFICATE
</FONT>OF <FONT STYLE="color: #281D2F">FIDUCIARY POWERS</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: transparent">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I, Brian Brooks, Acting Comptroller of
the Currency, do hereby certify that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">1. The Office of the Comptroller of the
Currency, pursuant to Revised Statutes 324, et seq, as amended, and 12 USC 1, et seq, as amended, has possession, custody, and
control of all records pertaining to the chartering, regulation, and supervision of all national banking associations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">2. &ldquo;U.S. Bank National Association,&rdquo;
Cincinnati, Ohio (Charter No. 24), was granted, under the hand and seal of the Comptroller, the right to act in all fiduciary
capacities authorized under the provisions of the Act of Congress approved September 28, 1962, 76 Stat. 668, 12 USC 92a, and that
the authority so granted remains in full force and effect on the date of this certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">IN TESTIMONY WHEREOF, today,
December 4,2020, I have hereunto subscribed my name and caused my seal of office to be affixed to these presents at the U.S.
Department of the Treasury, in the City of Washington, District of Columbia.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>



<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top; background-color: white">
    <TD STYLE="width: 30%; font-size: 9.5pt; color: #333042">&nbsp;</td>
    <TD STYLE="width: 40%; font-size: 9.5pt; color: #333042; text-align: center; border-bottom: Black 1px solid"><IMG SRC="x1_c101351a003.jpg" ALT="">&nbsp;</td>
    <TD STYLE="width: 30%; font-size: 9.5pt; color: #333042">&nbsp;</td></tr>
<tr style="vertical-align: top; background-color: white">
    <TD STYLE="font-size: 9.5pt; color: #333042">&nbsp;</td>
    <TD STYLE="font-size: 10pt; color: #333042; text-align: center">Acting Comptroller of the Currency</td>
    <TD STYLE="font-size: 9.5pt; color: #333042">&nbsp;</td></tr>
</table>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="x1_c101351a002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">2021-00217-C</P>
</div>
<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; padding-bottom: 12pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><PAGE></PAGE></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Exhibit 6</U></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CONSENT</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">In accordance with Section
321(b) of the Trust Indenture Act of 1939, the undersigned, U.S. BANK NATIONAL ASSOCIATION hereby consents that reports of examination
of the undersigned by Federal, State, Territorial or District authorities may be furnished by such authorities to the Securities
and Exchange Commission upon its request therefor.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0">Dated: March 18, 2021</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <TD STYLE="width: 51%">&nbsp;</td>
    <TD STYLE="width: 4%">By:</td>
    <TD STYLE="width: 25%; border-bottom: Black 1px solid">/s/ Kathy L. Mitchell</td>
    <TD STYLE="width: 20%">&nbsp;</TD></tr>
<tr style="vertical-align: top">
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>Kathy L. Mitchell</td>
    <TD>&nbsp;</TD></tr>
<tr style="vertical-align: top">
    <TD>&nbsp;</td>
    <TD>&nbsp;</td>
    <TD>Vice President</td>
    <TD>&nbsp;</TD></tr>
</table>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; padding-bottom: 12pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 10pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 100%"><PAGE></PAGE></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Exhibit 7</U></B></P>

<P STYLE="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">U.S. Bank National Association<BR>
Statement of Financial Condition<BR>
As of 12/31/2020</P>

<P STYLE="font: bold 11pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>($000&rsquo;s) </B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 12pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1px solid">12/31/2020</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(229,255,255)">
    <TD STYLE="font-weight: bold">Assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 87%; text-align: left; padding-left: 0.125in">Cash and Balances Due From</TD><TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 8%; text-align: right">62,424,852</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(229,255,255)">
    <TD STYLE="text-align: left; padding-left: 20pt">Depository Institutions</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in">Securities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">135,372,305</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(229,255,255)">
    <TD STYLE="text-align: left; padding-left: 0.125in">Federal Funds</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">149</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.125in">Loans&nbsp;&amp; Lease Financing Receivables</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">299,153,643</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(229,255,255)">
    <TD STYLE="text-align: left; padding-left: 0.125in">Fixed Assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,454,095</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.125in">Intangible Assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12,786,750</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(229,255,255)">
    <TD STYLE="text-align: left; padding-left: 0.125in; padding-bottom: 1pt">Other Assets</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1px solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1px solid">27,582,366</TD><TD STYLE="text-align: left; padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-left: 0.125in">Total Assets</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">$</TD><TD STYLE="font-weight: bold; text-align: right">544,774,160</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(229,255,255)">
    <TD STYLE="font-weight: bold">Liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in">Deposits</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">442,835,836</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(229,255,255)">
    <TD STYLE="text-align: left; padding-left: 0.125in">Fed Funds</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,175,229</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.125in">Treasury Demand Notes</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(229,255,255)">
    <TD STYLE="text-align: left; padding-left: 0.125in">Trading Liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,036,903</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.125in">Other Borrowed Money</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">27,992,840</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(229,255,255)">
    <TD STYLE="padding-left: 0.125in">Acceptances</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.125in">Subordinated Notes and Debentures</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,850,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(229,255,255)">
    <TD STYLE="text-align: left; padding-left: 0.125in; padding-bottom: 1pt">Other Liabilities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1px solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1px solid">14,494,315</TD><TD STYLE="text-align: left; padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-left: 0.125in">Total Liabilities</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">$</TD><TD STYLE="font-weight: bold; text-align: right">491,385,123</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(229,255,255)">
    <TD STYLE="font-weight: bold">Equity</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.125in">Common and Preferred Stock</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">18,200</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(229,255,255)">
    <TD STYLE="padding-left: 0.125in">Surplus</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">14,266,915</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.125in">Undivided Profits</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">38,303,599</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(229,255,255)">
    <TD STYLE="text-align: left; padding-left: 0.125in; padding-bottom: 1pt">Minority Interest in Subsidiaries</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1px solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1px solid">800,323</TD><TD STYLE="text-align: left; padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-left: 0.375in">Total Equity Capital</TD><TD STYLE="font-weight: bold">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">$</TD><TD STYLE="font-weight: bold; text-align: right">53,389,037</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(229,255,255)">
    <TD STYLE="font-weight: bold; text-align: left">Total Liabilities and Equity Capital</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">$</TD><TD STYLE="font-weight: bold; text-align: right">544,774,160</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
</TABLE>





<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 10pt; margin-bottom: 6pt; padding-bottom: 12pt; border-bottom: Silver 4px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>x1_c101351a001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 x1_c101351a001.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  R "T# 2(  A$! Q$!_\0
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M^%_%7AW48[_2-8TVXGT[6="UK3I\QS03Q-'/;W%K<Q%)4R VUXW!4U_I8_\
M!(K]L34/VUOV)/AG\3O%-U'<?$?0([CP#\2&\Q7GNO$_A@I9MK-Q&JKY#Z_9
M"VU4QG)#SR$$@@U_G_?\%!O"WAOP7^W-^U?X:\(_9U\/:=\;?&HL;>S5$M+
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MPYH$P&Z1L"32M-M' W?-@-C//6BBOK,J_P"2;SO_ +",+_Z14/*Q7_(QP/\
/@J_^ETSZ$HHHKY,]4__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>x1_c101351a003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 x1_c101351a003.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !! /(# 2(  A$! Q$!_\0
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MX!QWP21G'U'\_3EU !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MJ:WA*&<QC)=<AOE8*& !QDYSG.>G0$ DY(^)OV@?^">'[)W[2/Q'T3XV^/\
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MD\4^)M2M])T71],LXFFN+J[O+IT08C4^1"F^:ZF,<%O')+(B, 9_Q3\":?\
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M]0GM'OH;?_A+HK"06R;#(\K:G#9QVS)N4213R1S DH8PP./RE_9H_P"">?\
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50 4444 %+V'U/\EHHH 2BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>x1_c101351a002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 x1_c101351a002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #0 ,@# 2(  A$! Q$!_\0
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M 2S+*<AABOJ6*S&A&I[-8[.\4J=6MD.22FX1HU9499CF=2<:.6X6K+67\_\
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MZL(5:4X5:=2,9TZE.<:E.<)).,X3A*4)1DFFI1DTT[IA1114EA1110 4444
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M/Q+\<-9UK5;O35F\7WUC=6^L76I6NE:=IUW'HFG%+?1_[<:[*30V][<5ZE#
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MV=N!_6OGC(Y^H//IT'3Z"OF?$WA./"?$LX8./+DN=4(9UD?-*#J4<%BYS5;
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M9)7S'-95)YKA,;@\%2K5</@J676P*FH*5.GB[TU)47$\?Q:QF$HX3AKPRRS
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M6HM6NM&TC3>&UCPK\._&<=DG]JW/VFTTJ")-((@-S*9_ZCOV7?CMH'[2_P
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M$V$,=Q<?%OXF>$?!=ZWG.ES86%K'?^*WN8HXV!D,L^@VED4<%&6\?*D\!O\
MP3PM;?6?VR_BUH5I:K;>'?V5?V0OV5?@3X9MU1WBM=2\1:7KOBSQG:JTP\RR
MU&QU33;:VU2W8M<3E[9[ALQ*H^0_^"[\WB/XG_&#X!?LZ^')9+G5O%GC?X:R
MZ)I<Q"V3ZUKM]XET2UE8@;E9OE1FR0$!QR*_1K_@E1H\=Y)^V]\2&B5;CQ_^
MVA\4A!*^7OHM%\)VVC:#INEW,YSYD6GW,6J-;!28XX[IE4*VZOZ*QN$H9'X%
M9/445/&9K2SG&NTXKDJ9UG62Y;0K5:3][F>69;F%"A5BN516(IWO.27\K4<7
M7S_Z0>8TN::PF3U<IP24HMPE')LGS3,:]*G..G_(PQV$Q%6#>ZIR:=HM?*'_
M  6L\2^+/AI\;/V*_BO\2/"&L_$_]B_P=XEUNX^+_P .M-TR;4M$N_&"2V[Z
M3JOBZW%N=,N((]*EE'ARV\0W2:9<ZG:75K'&9[DM7D_[6WQM_P""*OQK_8Y\
M6ZAX4C^&-OXF\*:!XKO_ (3>!?"^C:OX#\<Z)\4O%&E0O:I8^'=$MM,CN+Z[
MO['3A>7=Q%J&C+):JDEQDX;]SOVNOVE?V9_V<_AO=ZA^TSXB\,V'AKQ1IWB"
MWTCPAXAM(M4NOB#<:+IZZAJ'AS0-%GAFAUC59;>6$QV3A QEC;>JJSK\6_LJ
M?LQ?\$H/VB+;P[\=_@#\&OA-K&JZ='H/BJ;2;2U\S4/ NKZE'-=Z99>(_"YN
MY[71-5AGL;IXM/NK<(9K.2:WBDB1)*X.&N),#@^$N&\SSO(^/,OP_"6.K4LM
MSSA/%1PF19U4GCJN/>#SB&*@L-#%RJU)X*MCJ,JU2KAY?5ZCYH1H'L<5\+8S
M&\:<395DF?\  .88GB[ X>OF&1<58:6*S_)(0P=++_K>3U<+56)>%]E"&+HX
M*JZ5.G77MX1<)2JOXYN_^"DWQ9_X)W?LA_L$^&?C[X*\7>//B9\1M!M-?\:Z
MWJUDT_D?"C2;D-J>EQ7@N[.]E^)F@>'==\&A=-U.U2%6G(U&YDE:1%_HL\.Z
MNVOZ!HFN/IE]HSZQI=CJ9TC5HX8]4TXWUO'<"RU".":Y@AO+<2"*YBCGF6.9
M702-MR<;5=(^'WBK5I=+US2_"GB'6M$L8S)I^JV6EZIJ&EZ;KSRI&QMKN.:6
MSL]8DTB90=D<5\VF.I,IM"(^S5510JJ$2,!$51@*H"@  #  Z #H!7YAQ+G>
M49W3PM;"\/0R?.)XW-\?F^,HXFJ\+CUF>,GC,'2PF E3A3P5' TJCH0=-S56
M#4ERK0_6>$L@SK(:N,P^,XG>>9-1P.49?E&"JX:E'$Y?++<''"XNKBL9"I4J
M8JMCJD%6FJB@Z<[I\SM(\Y^)?PA^%WQDT.'PW\5_ 'A'XA:#;W*WUMI/B_0K
M#7K*VO0CP_;+:#4(9TM[E(Y607$(25%9L.,\?S5?M%_&S5OV5_VF?C%^Q?\
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MV3>J;3V\TS^H(R4HJ2VDDUZ-71_+5_P4TUR[NO\ @L=^Q1X08@V47B']G_7
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MT*\O)M0EMW:[EMK*)S-\B_\ !-/]LSQ#X+^('@_]GGX@S?&OXOZI^TU>Z_\
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M;J-\Q;#_ #T?LO\ AS]I[]HG5OVD?C!_P3K_ &6?AG\$?A%XL^#?A_X"^(/
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M&\*:-;MM-[/##=:A*@58M,T+2HR+S5M0D+QI%9:=!-(H(=U2)6D7^>K]N/\
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M&78K+J=\/*G+$4\9PWF5*>"PBQN&=50K5<LI27#>;PI8AU</CLMRS&5Y8?\
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M_P %,OVT/"'P#^+OQLF_:*^"7QF^'7P#\1R>&M)^%/QC0Z5\;/B7X<U2^9-
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MHO#+V<MO<_MO?'KP\WVS1_!G@L22PQO\-/AW<6*:KXL\22K<V\OV][:YL41
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MCM9I 6#L91"TD<;(7)/\@_[0.G_M0_LB>(_ WPQ_;O\ A;X@_:.^ /PPV_\
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M634/ NG^);2338/ EQIFHV$R>)-(\,VNMPWUWK%WK-U;ZK%;26A4RK/^?_\
MP2I^"?A/Q!\>=#\4^$?V._B/^U%\/]#^.*Z1X#_:-\6ZW=>#/A_X&\!:3?\
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M-E!8ZGXA/A6PNM2U&*"5IE,K:@+Y(6$KE\V_E9/7( %?8J(L:HJ*J*HP%50
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%110!_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
